Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
189000,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Bacteroides Uniformis Atcc8492 And A Corresponding Drug Metabolite With M/Z 294.162 At Retention Time 3.438 Minutes Is Detected.,25382767,[],CHEMBL5303602,The drug is tested on Bacteroides uniformis strain: ATCC8492 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189001,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Bifidobacterium Ruminantium Fecal Isolate And A Corresponding Drug Metabolite With M/Z 342.183 At Retention Time 3.344 Minutes Is Detected.,25383075,[],CHEMBL5303577,The drug is tested on Bifidobacterium ruminantium strain: fecal isolate for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189002,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Bifidobacterium Ruminantium Fecal Isolate And A Corresponding Drug Metabolite With M/Z 360.194 At Retention Time 3.345 Minutes Is Detected.,25383081,[],CHEMBL5303577,The drug is tested on Bifidobacterium ruminantium strain: fecal isolate for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189003,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Akkermansia Muciniphila Atcc Baa-835 And A Corresponding Drug Metabolite With M/Z 294.162 At Retention Time 3.438 Minutes Is Detected.,25383144,[],CHEMBL5303649,The drug is tested on Akkermansia muciniphila strain: ATCC BAA-835 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189004,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Akkermansia Muciniphila Atcc Baa-835 And A Corresponding Drug Metabolite With M/Z 360.194 At Retention Time 3.828 Minutes Is Detected.,25383170,[],CHEMBL5303649,The drug is tested on Akkermansia muciniphila strain: ATCC BAA-835 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189005,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Akkermansia Muciniphila Atcc Baa-835 And A Corresponding Drug Metabolite With M/Z 360.194 At Retention Time 3.345 Minutes Is Detected.,25383171,[],CHEMBL5303649,The drug is tested on Akkermansia muciniphila strain: ATCC BAA-835 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189006,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Providencia Alcalifaciens Dsm30120 And A Corresponding Drug Metabolite With M/Z 294.162 At Retention Time 3.438 Minutes Is Detected.,25383230,[],CHEMBL5303645,The drug is tested on Providencia alcalifaciens strain: DSM30120 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189007,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Odoribacter Splanchnicus Fecal Isolate And A Corresponding Drug Metabolite With M/Z 294.162 At Retention Time 3.438 Minutes Is Detected.,25383609,[],CHEMBL5303606,The drug is tested on Odoribacter splanchnicus strain: fecal isolate for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189008,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Clostridium Sporogenes Atcc15579 And A Corresponding Drug Metabolite With M/Z 357.2 At Retention Time 1.598 Minutes Is Detected.,25384290,[],CHEMBL5303625,The drug is tested on Clostridium sporogenes strain: ATCC15579 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189009,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Clostridium Sporogenes Atcc15579 And A Corresponding Drug Metabolite With M/Z 360.194 At Retention Time 3.345 Minutes Is Detected.,25384293,[],CHEMBL5303625,The drug is tested on Clostridium sporogenes strain: ATCC15579 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189010,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Clostridium Sporogenes Atcc15579 And A Corresponding Drug Metabolite With M/Z 382.178 At Retention Time 3.952 Minutes Is Detected.,25384300,[],CHEMBL5303625,The drug is tested on Clostridium sporogenes strain: ATCC15579 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189011,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Clostridium Sporogenes Atcc15579 And A Corresponding Drug Metabolite With M/Z 400.189 At Retention Time 3.953 Minutes Is Detected.,25384307,[],CHEMBL5303625,The drug is tested on Clostridium sporogenes strain: ATCC15579 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189012,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Clostridium Sporogenes Atcc15579 And A Corresponding Drug Metabolite With M/Z 402.204 At Retention Time 3.989 Minutes Is Detected.,25384308,[],CHEMBL5303625,The drug is tested on Clostridium sporogenes strain: ATCC15579 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189013,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Eubacterium Biforme Dsm3989 And A Corresponding Drug Metabolite With M/Z 360.194 At Retention Time 3.828 Minutes Is Detected.,25384592,[],CHEMBL5303630,The drug is tested on Eubacterium biforme strain: DSM3989 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189014,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Eubacterium Biforme Dsm3989 And A Corresponding Drug Metabolite With M/Z 444.146 At Retention Time 3.772 Minutes Is Detected.,25384601,[],CHEMBL5303630,The drug is tested on Eubacterium biforme strain: DSM3989 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189015,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Putative Metabolite Identification: The Drug  Fluconazole Is Biotransformed By Bacteroides Thetaiotaomicron Vpi-5482 And A Corresponding Drug Metabolite With M/Z 294.162 At Retention Time 3.438 Minutes Is Detected.,25384711,[],CHEMBL5303599,The drug is tested on Bacteroides thetaiotaomicron strain: VPI-5482 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189016,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",The Percentage Of Consumption Of The Drug Fluconazole I.E. 23.445 % Is Higher Than The Drug Adaptive Fc Threshold 20%. Significant Biotransformation Is Detected.,25385407,[],CHEMBL5303614,The drug is tested on Blautia hansenii strain: DSM20583 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189017,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",The Percentage Of Consumption Of The Drug Fluconazole I.E. 25.722 % Is Higher Than The Drug Adaptive Fc Threshold 20%. Significant Biotransformation Is Detected.,25385463,[],CHEMBL5303621,The drug is tested on Clostridium sp. strain: fecal isolate for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189018,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",The Percentage Of Consumption Of The Drug Fluconazole I.E. 21.109 % Is Higher Than The Drug Adaptive Fc Threshold 20%. Significant Biotransformation Is Detected.,25385864,[],CHEMBL5303588,The drug is tested on Bacteroides fragilis strain: NCTC 9343 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189019,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",The Percentage Of Consumption Of The Drug Fluconazole I.E. 28.756 % Is Higher Than The Drug Adaptive Fc Threshold 20%. Significant Biotransformation Is Detected.,25385901,[],CHEMBL5303605,The drug is tested on Bacteroides xylanisolvens strain: DSM18836 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189020,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",The Percentage Of Consumption Of The Drug Fluconazole I.E. 25.891 % Is Higher Than The Drug Adaptive Fc Threshold 20%. Significant Biotransformation Is Detected.,25386004,[],CHEMBL5303598,The drug is tested on Bacteroides stercoris strain: ATCC43183 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189021,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",The Percentage Of Consumption Of The Drug Fluconazole I.E. 23.352 % Is Higher Than The Drug Adaptive Fc Threshold 20%. Significant Biotransformation Is Detected.,25386134,[],CHEMBL5303596,The drug is tested on Bacteroides ovatus strain: ATCC8483 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189022,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",The Percentage Of Consumption Of The Drug Fluconazole I.E. 21.869 % Is Higher Than The Drug Adaptive Fc Threshold 20%. Significant Biotransformation Is Detected.,25386376,[],CHEMBL5303601,The drug is tested on Bacteroides thetaiotaomicron strain: 7330 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189023,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",The Percentage Of Consumption Of The Drug Fluconazole I.E. 34.268 % Is Higher Than The Drug Adaptive Fc Threshold 20%. Significant Biotransformation Is Detected.,25386417,[],CHEMBL5303589,The drug is tested on Bacteroides fragilis strain: 3397 (T10) for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189024,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",The Percentage Of Consumption Of The Drug Fluconazole I.E. 34.499 % Is Higher Than The Drug Adaptive Fc Threshold 20%. Significant Biotransformation Is Detected.,25386487,[],CHEMBL5303590,The drug is tested on Bacteroides fragilis strain: T(B)9 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189025,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",The Percentage Of Consumption Of The Drug Fluconazole I.E. 37.788 % Is Higher Than The Drug Adaptive Fc Threshold 20%. Significant Biotransformation Is Detected.,25386604,[],CHEMBL5303592,The drug is tested on Bacteroides fragilis strain: HMW610 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound metabolized,,Biotransformation,,,,
189026,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 13.778 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25386883,[],CHEMBL5303582,The drug is tested on Bacteroides caccae strain: ATCC43185 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189027,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 1.14 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25387060,[],CHEMBL5303643,The drug is tested on Escherichia coli strain: BW25113 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189028,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 2.558 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25387218,[],CHEMBL5303622,The drug is tested on Clostridium ramosum strain: DSM1402 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189029,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25387401,[],CHEMBL5303574,The drug is tested on Bifidobacterium adolescentis strain: ATCC 15703 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189030,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 12.562 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25388327,[],CHEMBL5303583,The drug is tested on Bacteroides cellulosilyticus strain: DSM14838 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189031,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25388603,[],CHEMBL5303578,The drug is tested on Collinsella aerofaciens strain: ATCC25986 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189032,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25388993,[],CHEMBL5303611,The drug is tested on Anaerococcus hydrogenalis strain: DSM7454 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189033,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 17.293 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25389597,[],CHEMBL5303618,The drug is tested on Clostridium bolteae strain: ATCCBAA-613 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189034,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 13.503 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25390002,[],CHEMBL5303587,The drug is tested on Bacteroides finegoldii strain: DSM17565 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189035,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25390323,[],CHEMBL5303612,The drug is tested on Anaerostipes sp. strain: fecal isolate for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189036,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25390537,[],CHEMBL5303633,The drug is tested on Eubacterium ventriosum strain: ATCC27560 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189037,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25390738,[],CHEMBL5303637,The drug is tested on Ruminococcus lactaris strain: ATCC29176 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189038,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25390935,[],CHEMBL5303644,The drug is tested on Proteus penneri strain: ATCC35198 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189039,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25391146,[],CHEMBL5303641,The drug is tested on Edwardsiella tarda strain: ATCC23685 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189040,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25391558,[],CHEMBL5303642,The drug is tested on Enterobacter cancerogenus strain: ATCC35316 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189041,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 13.27 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25392279,[],CHEMBL5303607,The drug is tested on Parabacteroides distasonis strain: ATCC8503 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189042,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25392434,[],CHEMBL5303597,The drug is tested on Bacteroides pectinophilus strain: ATCC43243 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189043,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 16.887 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25392623,[],CHEMBL5303610,The drug is tested on Prevotella copri strain: DSM18205 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189044,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 2.553 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25392783,[],CHEMBL5303617,The drug is tested on Clostridium asparagiforme strain: DSM15981 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189045,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25392935,[],CHEMBL5303575,The drug is tested on Bifidobacterium breve strain: DSM20213 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189046,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25393531,[],CHEMBL5303576,The drug is tested on Bifidobacterium longum subsp. Infantis strain: CCUG52486 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189047,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25394205,[],CHEMBL5303634,The drug is tested on Lactobacillus  reuteri CF48-3A strain: BEI HM-102 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189048,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25395364,[],CHEMBL5303579,The drug is tested on Collinsella intestinalis strain: DSM13280 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189049,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25395583,[],CHEMBL5303615,The drug is tested on Blautia luti strain: DSM14534 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189050,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 18.752 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25396251,[],CHEMBL5303609,The drug is tested on Parabacteroides merdae strain: ATCC43184 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189051,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 19.409 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25396419,[],CHEMBL5303584,The drug is tested on Bacteroides coprophilus strain: DSM18228 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189052,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 10.595 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25396596,[],CHEMBL5303604,The drug is tested on Bacteroides sp. WH2 strain: WH2 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189053,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25397294,[],CHEMBL5303629,The drug is tested on Enterococcus faecalis strain: V583 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189054,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25397471,[],CHEMBL5303616,The drug is tested on Marvinbryantia formatexigens strain: DSM14469 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189055,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 12.613 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25397629,[],CHEMBL5303581,The drug is tested on Alistipes indistinctus strain: DSM22520 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189056,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25397924,[],CHEMBL5303619,The drug is tested on Clostridium difficile strain: 120 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189057,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 0 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25398687,[],CHEMBL5303648,The drug is tested on Salmonella typhimurium strain: LT2 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189058,,The Percentage Of Consumption Of The Drug Fluconazole I.E. 2.181 % Is Lower Than The Drug Adaptive Fc Threshold 20%. No Significant Biotransformation Is Detected.,25398830,[],CHEMBL5303580,The drug is tested on Eggerthella lenta strain: ATCC25559 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC–MS),A,,,BAO_0000179,BAO_0000019,assay format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL5303573,Nature,2019.0,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,3942842,,69,0,,Compound NOT metabolized,Biotransformation,,,,CHEMBL612558,,ADMET,,Compound NOT metabolized,,Biotransformation,,,,
189059,,,734076,[],CHEMBL813122,Minimum inhibitory concentration (MIC) against Staphylococcus aureus 6538p.,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
189060,,,734077,[],CHEMBL813808,Minimum inhibitory concentration (MIC) against Staphylococcus aureus giorgio,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
189061,,,734078,[],CHEMBL813121,Minimum inhibitory concentration (MIC) against Staphylococcus aureus 241,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189062,,,734079,[],CHEMBL813397,Minimum inhibitory concentration (MIC) against Staphylococcus epidermidis 887E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.008
189063,,,734080,[],CHEMBL813398,Minimum inhibitory concentration (MIC) against Staphylococcus epidermidis 178,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,4.0
189064,,,734081,[],CHEMBL650969,Minimum inhibitory concentration (MIC) against Bacillus subtilis ATCC 6633,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.008
189065,,,734082,[],CHEMBL814011,Minimum inhibitory concentration (MIC) against Streptococcus faecalis 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.063
189066,,,734083,[],CHEMBL674097,Minimum inhibitory concentration (MIC) against Escherichia coli 10536,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
189067,,,734084,[],CHEMBL674098,Minimum inhibitory concentration (MIC) against Escherichia coli 3190Y,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
189068,,,734085,[],CHEMBL674099,Minimum inhibitory concentration (MIC) against Escherichia coli TEM9 2639E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.031
189069,,,734086,[],CHEMBL765948,Minimum inhibitory concentration (MIC) against Pseudomonas aeruginosa 1912E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
189070,,,734087,[],CHEMBL877686,Minimum inhibitory concentration (MIC) against Enterobacter cloacae P99,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.008
189071,,,734088,[],CHEMBL703219,Minimum inhibitory concentration (MIC) against Klebsiella aerogenes 1082E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.031
189072,,,734089,[],CHEMBL636956,Minimum inhibitory concentration (MIC) against Acinetobacter calcoaceticus 15473,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227151,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,0.063
189073,,,745873,[],CHEMBL813122,Minimum inhibitory concentration (MIC) against Staphylococcus aureus 6538p.,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
189074,,,745874,[],CHEMBL813808,Minimum inhibitory concentration (MIC) against Staphylococcus aureus giorgio,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
189075,,,745875,[],CHEMBL813121,Minimum inhibitory concentration (MIC) against Staphylococcus aureus 241,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189076,,,745876,[],CHEMBL813397,Minimum inhibitory concentration (MIC) against Staphylococcus epidermidis 887E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.008
189077,,,745877,[],CHEMBL813398,Minimum inhibitory concentration (MIC) against Staphylococcus epidermidis 178,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,4.0
189078,,,745878,[],CHEMBL650969,Minimum inhibitory concentration (MIC) against Bacillus subtilis ATCC 6633,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.008
189079,,,745879,[],CHEMBL814011,Minimum inhibitory concentration (MIC) against Streptococcus faecalis 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.063
189080,,,745880,[],CHEMBL674097,Minimum inhibitory concentration (MIC) against Escherichia coli 10536,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
189081,,,745881,[],CHEMBL674098,Minimum inhibitory concentration (MIC) against Escherichia coli 3190Y,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
189082,,,745882,[],CHEMBL674099,Minimum inhibitory concentration (MIC) against Escherichia coli TEM9 2639E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.031
189083,,,745883,[],CHEMBL765948,Minimum inhibitory concentration (MIC) against Pseudomonas aeruginosa 1912E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
189084,,,745884,[],CHEMBL877686,Minimum inhibitory concentration (MIC) against Enterobacter cloacae P99,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.008
189085,,,745885,[],CHEMBL703219,Minimum inhibitory concentration (MIC) against Klebsiella aerogenes 1082E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.031
189086,,,745886,[],CHEMBL636956,Minimum inhibitory concentration (MIC) against Acinetobacter calcoaceticus 15473,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,0.063
189087,,,745887,[],CHEMBL738472,Minimum inhibitory concentration (MIC) against systemic infection in mouse by Staphylococcus aureus giorgio,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MIC,ug ml-1,UO_0000274,,0.008
189088,,,745888,[],CHEMBL738473,Minimum inhibitory concentration (MIC) against systemic infection in mouse by Streptococcus pneumoniae 77A,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MIC,ug ml-1,UO_0000274,,0.016
189089,,,745889,[],CHEMBL738471,Minimum inhibitory concentration (MIC) against systemic infection in mouse by Pseudomonas aeruginosa 1912E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MIC,ug ml-1,UO_0000274,,0.25
189090,,,745890,[],CHEMBL738470,Minimum inhibitory concentration (MIC) against systemic infection in mouse by Escherichia coli 851E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,227152,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MIC,ug ml-1,UO_0000274,,0.008
189091,,,745891,[],CHEMBL734122,50% Effective dose against systemic Infection in mouse by Staphylococcus aureus giorgio,F,,,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,227152,=,1,1,=,,ED50,mg.kg-1,,1.17,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,1.17
189092,,,745892,[],CHEMBL734123,50% Effective dose against systemic Infection in mouse by Streptococcus pneumoniae 77A,F,,,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,227152,=,1,1,=,,ED50,mg.kg-1,,7.64,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,7.64
189093,,,745893,[],CHEMBL734121,50% Effective dose against systemic Infection in mouse by Pseudomonas aeruginosa 1912E,F,,,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,227152,=,1,1,=,,ED50,mg.kg-1,,2.08,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,2.08
189094,,,745894,[],CHEMBL734120,50% Effective dose against systemic Infection in mouse by Escherichia coli 851E,F,,,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,227152,=,1,1,=,,ED50,mg.kg-1,,0.47,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,0.47
189095,,,745895,[],CHEMBL627849,Area under curve was determined in Rats after peroral administration,A,,,BAO_0002120,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,227152,=,1,1,=,,AUC,ng.hr.mL-1,,8500.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,ug hr ml-1,,,8.5
189096,,,745896,[],CHEMBL627848,Area under curve was determined in Dogs after peroral administration,A,,,BAO_0002120,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,227152,=,1,1,=,,AUC,ng.hr.mL-1,,7550.0,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,AUC,ug hr ml-1,,,7.55
189097,,,745897,[],CHEMBL639837,Half-life in Rats was determined after Peroral administration,A,,,BAO_0002115,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,227152,=,1,1,=,,T1/2,hr,,2.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,T1/2,hr,UO_0000032,,2.33
189098,,,745898,[],CHEMBL639835,Half-life in Dogs was determined after Peroral administration,A,,,BAO_0002115,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,227152,=,1,1,=,,T1/2,hr,,5.12,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,T1/2,hr,UO_0000032,,5.12
189099,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,745899,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL623292,maximum Plasma concentration in Rats was determined after Peroral administration,A,,,BAO_0002119,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,227152,=,1,1,=,,Cmax,nM,,6266.21,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Cmax,ug ml-1,UO_0000065,,2.44
189100,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,745900,"[{'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL623291,maximum Plasma concentration in Dog was determined after Peroral administration,A,,,BAO_0002119,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,227152,=,1,1,=,,Cmax,nM,,3441.28,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,Cmax,ug ml-1,UO_0000065,,1.34
189101,,,745901,[],CHEMBL633566,Tmax was determined in Rats after Peroral administration,A,,,BAO_0003037,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,227152,=,1,1,=,,Tmax,hr,,0.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,T max,hr,UO_0000032,,0.33
189102,,,745902,[],CHEMBL633567,Tmax was determined in dogs after Peroral administration,A,,,BAO_0003037,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,227152,=,1,1,=,,Tmax,hr,,1.13,CHEMBL373,Canis lupus familiaris,Canis familiaris,9615.0,,,T max,hr,UO_0000032,,1.13
189103,,,745903,[],CHEMBL631055,Oral bioavailability in rat,A,,,BAO_0003042,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,227152,=,1,1,=,,F,%,,95.3,CHEMBL612558,,ADMET,,,,F,%,UO_0000187,,95.3
189104,,,745904,[],CHEMBL631054,Oral Bioavailability was determined in Dogs after Peroral administration,A,,,BAO_0003042,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1130203,J Med Chem,1997.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,227152,=,1,1,=,,F,%,,71.0,CHEMBL612558,,ADMET,,,,F,%,UO_0000187,,71.0
189105,,,947384,[],CHEMBL810350,Antibacterial activity was determined against clinically isolated Levofloxacin-methicillin resistant Staphylococcus aureus (LVFX-r MRSA) strains (74 strains),F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1760,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,2.0
189106,,,947385,[],CHEMBL807739,Antibacterial activity was determined against clinically isolated Levofloxacin-methicillin resistant Staphylococcus aureus (LVFX-r MRSA) strains (74 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1760,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,32.0
189107,,,947386,[],CHEMBL814672,Antibacterial activity was determined against clinically isolated penicillin resistant Streptococcus pneumoniae (PRSP) strains (50 strains),F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1760,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
189108,,,947387,[],CHEMBL817379,Antibacterial activity was determined against clinically isolated penicillin resistant Streptococcus pneumoniae (PRSP) strains (50 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1760,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.06
189109,,,947388,[],CHEMBL673550,Antibacterial activity was determined against clinically isolated vancomycin-A resistant Enterococci (VRE) strains (33 strains),F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1760,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,MIC50,ug ml-1,UO_0000274,,4.0
189110,,,947389,[],CHEMBL674200,Antibacterial activity was determined against clinically isolated vancomycin-A resistant Enterococci (VRE) strains (33 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1760,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,MIC90,ug ml-1,UO_0000274,,32.0
189111,,,947390,[],CHEMBL673552,Antibacterial activity was determined against clinically isolated vancomycin-B resistant Enterococci (VRE) strains (10 strains),F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1760,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,MIC50,ug ml-1,UO_0000274,,1.0
189112,,,947391,[],CHEMBL674201,Antibacterial activity was determined against clinically isolated vancomycin-B resistant Enterococci (VRE) strains (10 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1760,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,MIC90,ug ml-1,UO_0000274,,2.0
189113,,,1108987,[],CHEMBL813961,In vitro antibacterial activity against the Streptococcus pyogenes 308A,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.195
189114,,,1108988,[],CHEMBL813962,In vitro antibacterial activity against the Streptococcus pyogenes 77A,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.025
189115,,,1108989,[],CHEMBL811377,In vitro antibacterial activity against the Staphylococcus aureus SG511,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.013,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.013
189116,,,1108990,[],CHEMBL883627,In vitro antibacterial activity against the Staphylococcus aureus 285,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.025
189117,,,1108991,[],CHEMBL676273,In vitro antibacterial activity against the Escherichia coli 078,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.007,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.007
189118,,,1108992,[],CHEMBL878407,In vitro antibacterial activity against the Escherichia coli DC 2,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
189119,,,1108993,[],CHEMBL771129,In vitro antibacterial activity against the Pseudomonas aeruginosa 1592E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.391,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.391
189120,,,1108994,[],CHEMBL771130,In vitro antibacterial activity against the Pseudomonas aeruginosa 1771M,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.195
189121,,,1108995,[],CHEMBL801689,In vitro antibacterial activity against the Salmonella Typhimurium,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.004
189122,,,1108996,[],CHEMBL675788,In vitro antibacterial activity against the Enterobacter cloacae 1321 E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.004
189123,,,1108997,[],CHEMBL808683,In vitro antibacterial activity against the Methicillin-Resistant Staphylococcus aureus (MRSA) 690 E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.098
189124,,,1108998,[],CHEMBL808684,In vitro antibacterial activity against the Methicillin-Resistant Staphylococcus aureus (MRSA) 692 E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.049
189125,,,1108999,[],CHEMBL808685,In vitro antibacterial activity against the Methicillin-Resistant Staphylococcus aureus (MRSA) 697 E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.049,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.049
189126,,,1109000,[],CHEMBL808686,In vitro antibacterial activity against the Methicillin-Resistant Staphylococcus aureus (MRSA) 701 E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.098
189127,,,1109001,[],CHEMBL808687,In vitro antibacterial activity against the Methicillin-Resistant Staphylococcus aureus (MRSA) 705 E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.098
189128,,,1109002,[],CHEMBL808688,In vitro antibacterial activity against the Methicillin-Resistant Staphylococcus aureus (MRSA) 707 E,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.025
189129,,,1109003,[],CHEMBL808673,In vitro antibacterial activity against the Ofloxacin Resistant Staphylococcus aureus 179,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.781,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.781
189130,,,1109004,[],CHEMBL808681,In vitro antibacterial activity against the Ofloxacin Resistant Staphylococcus aureus 293,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.781,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.781
189131,,,1109005,[],CHEMBL808682,In vitro antibacterial activity against the Ofloxacin Resistant Staphylococcus aureus 303,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.781,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.781
189132,,,1109006,[],CHEMBL804392,In vitro antibacterial activity against the Ofloxacin Resistant Staphylococcus epidermidis 291,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,1.563,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.563
189133,,,1109007,[],CHEMBL804394,In vitro antibacterial activity against the Ofloxacin Resistant Staphylococcus epidermidis 319,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,3.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,3.125
189134,,,1109008,[],CHEMBL674294,In vitro antibacterial activity against the Ofloxacin Resistant Enterococcus knothe 101,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.098,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,MIC,ug ml-1,UO_0000274,,0.098
189135,,,1109009,[],CHEMBL764222,In vitro antibacterial activity against the Ofloxacin Resistant Pseudomonas aeruginosa 279II,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,6.25
189136,,,1109010,[],CHEMBL704917,In vitro antibacterial activity against the Ofloxacin Resistant Klebsiella species 30-92,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,MIC,ug.mL-1,,0.781,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.781
189137,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,1109011,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}]",CHEMBL622923,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,A,,,BAO_0002119,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,32043,=,1,1,=,,Cmax,nM,,17026.63,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Cmax,ug ml-1,UO_0000065,,6.63
189138,,,1109012,[],CHEMBL622462,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,A,,,BAO_0003037,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,32043,=,1,1,=,,Tmax,hr,,1.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,T max,hr,UO_0000032,,1.0
189139,,,1109013,[],CHEMBL620483,Half-life period for the compound was determined in rats at 50 mg/kg dose,A,,,BAO_0002115,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,32043,=,1,1,=,,T1/2,hr,,2.12,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,T1/2,hr,UO_0000032,,2.12
189140,,,1109014,[],CHEMBL622024,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,A,,,BAO_0002120,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,32043,=,1,1,=,,AUC,ng.hr.mL-1,,25790.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,AUC,ug hr ml-1,,,25.79
189141,,,1109015,[],CHEMBL820949,Cytotoxicity was determined for the compound in V79-4 cell line,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,IC50,ug.mL-1,,10.08,CHEMBL612801,Cricetulus griseus,V79-4,10029.0,,,IC50,ug ml-1,UO_0000274,,10.08
189142,,,1109016,[],CHEMBL693800,Cytotoxicity was determined for the compound in HepG2 cell line,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147605,Bioorg Med Chem Lett,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,32043,=,1,1,=,,IC50,ug.mL-1,,13.49,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,ug ml-1,UO_0000274,,13.49
189143,,,1695218,[],CHEMBL865595,Antimicrobial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441546,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
189144,,,1695255,[],CHEMBL865596,Antimicrobial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441546,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
189145,,,1695292,[],CHEMBL865597,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 700699,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441546,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
189146,,,1695311,[],CHEMBL864433,Cytotoxicity against human Hep2 laryngeal carcinoma cell line,F,,,BAO_0000187,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,441546,=,1,1,=,,CC50,nM,,46000.0,CHEMBL614735,Homo sapiens,HEp-2,9606.0,,,CC50,uM,UO_0000065,,46.0
189147,,,1695506,[],CHEMBL863775,Inhibitory activity against wild type Escherichia coli gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,"{'bei': '16.18', 'le': '0.31', 'lle': '5.33', 'sei': '5.12'}",CHEMBL430,GEMIFLOXACIN,CHEMBL430,6.3,0,http://www.openphacts.org/units/Nanomolar,441546,=,1,1,=,,IC50,nM,,500.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,0.5
189148,,,1695522,[],CHEMBL864372,Inhibitory activity against wild type Staphylococcus aureus topoisomerase 4,B,,,BAO_0000190,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,"{'bei': '16.75', 'le': '0.32', 'lle': '5.55', 'sei': '5.30'}",CHEMBL430,GEMIFLOXACIN,CHEMBL430,6.52,0,http://www.openphacts.org/units/Nanomolar,441546,=,1,1,=,,IC50,nM,,300.0,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,,IC50,uM,UO_0000065,,0.3
189149,,,1804017,[],CHEMBL910493,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,621375,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
189150,,,1804028,[],CHEMBL910494,Cytotoxicity against human Hep2 cell line after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,621375,=,1,1,=,,CC50,nM,,46000.0,CHEMBL612558,,ADMET,,,,CC50,uM,UO_0000065,,46.0
189151,,,1804197,[],CHEMBL910518,Cytotoxicity against rat hepatocytes after 48 hrs,F,,,BAO_0000187,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,621375,>,1,1,>,,CC50,nM,,100000.0,CHEMBL613362,Rattus norvegicus,Hepatocyte,10116.0,,,CC50,uM,UO_0000065,,100.0
189152,,,1804203,[],CHEMBL910510,Inhibition of Staphylococcus aureus topoisomerase 4 by decatenation assay,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,6.52,0,http://www.openphacts.org/units/Nanomolar,621375,=,1,1,=,,IC50,nM,,300.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.3
189153,,,1804209,[],CHEMBL910511,Inhibition of Staphylococcus aureus DNA gyrase by supercoiling assay,B,,,BAO_0000190,BAO_0000223,protein complex format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139232,J Med Chem,2007.0,"{'bei': '13.49', 'le': '0.26', 'lle': '4.28', 'sei': '4.27'}",CHEMBL430,GEMIFLOXACIN,CHEMBL430,5.25,0,http://www.openphacts.org/units/Nanomolar,621375,=,1,1,=,,IC50,nM,,5600.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,5.6
189154,,,1804215,[],CHEMBL910512,Inhibition of human topoisomerase 2 by DNA cleavage assay,B,,,BAO_0000179,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Micromolar,621375,>,1,0,>,,EC2,uM,,150.0,CHEMBL1806,Homo sapiens,DNA topoisomerase II alpha,9606.0,,,EC2,uM,UO_0000064,,150.0
189155,,,1804221,[],CHEMBL910513,Antibacterial activity against methicillin-sensitive Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,621375,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
189156,,,1804227,[],CHEMBL910514,Antibacterial activity against fluoroquinolone-resistant Staphylococcus aureus 273/T/T/T,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,621375,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189157,,,1804233,[],CHEMBL910515,Cytotoxicity against human HepG2 cells after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1139232,J Med Chem,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,621375,=,1,1,=,,CC50,nM,,35000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,CC50,uM,UO_0000065,,35.0
189158,,,1833870,[],CHEMBL908132,Antimicrobial activity against Streptococcus pneumoniae R6,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189159,,,1833871,[],CHEMBL908133,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189160,,,1833872,[],CHEMBL908134,Antimicrobial activity agaisnt Streptococcus pneumoniae R6 transformants with parC S79Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189161,,,1833873,[],CHEMBL908135,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189162,,,1833874,[],CHEMBL908136,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189163,,,1833875,[],CHEMBL908137,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
189164,,,1833876,[],CHEMBL908138,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189165,,,1833877,[],CHEMBL908139,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
189166,,,1833878,[],CHEMBL908140,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79Y and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189167,,,1833879,[],CHEMBL908141,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79Y and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189168,,,1833881,[],CHEMBL908142,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189169,,,1833883,[],CHEMBL908143,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F and gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189170,,,1833884,[],CHEMBL908144,Antimicrobial activity agaisnt Streptococcus pneumoniae R6 transformants with parC S79F and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189171,,,1833885,[],CHEMBL908145,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
189172,,,1833886,[],CHEMBL908146,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189173,,,1833887,[],CHEMBL908147,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189174,,,1833888,[],CHEMBL908148,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189175,,,1833889,[],CHEMBL908149,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189176,,,1833890,[],CHEMBL908150,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625887,<,1,1,<,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189177,,,1866876,[],CHEMBL914188,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 150 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,634947,=,1,0,=,,fAUC/MIC,,,78.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,78.0
189178,,,1866987,[],CHEMBL915666,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 320 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,634947,=,1,0,=,,fAUC/MIC,,,146.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,146.0
189179,,,1868291,[],CHEMBL919811,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634868,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
189180,,Not Determined,1868295,[],CHEMBL919277,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus ATCC 29213 in presence of 20 ug/ml reserpine after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,634868,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
189181,,,1868297,[],CHEMBL919807,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus Mu50 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634868,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189182,,Not Determined,1868300,[],CHEMBL919813,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus Mu50 in presence of 20 ug/ml reserpine after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,634868,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
189183,,,1868301,[],CHEMBL919817,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus BSA643 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634868,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
189184,,,1868319,[],CHEMBL919278,Antibacterial activity against ethidium bromide-resistant Staphylococcus aureus BSA678 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634868,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
189185,,,1868961,[],CHEMBL914161,Peak free concentration at 75 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,0,=,,Activity,ug ml-1,,0.17,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,0.17
189186,,,1868995,[],CHEMBL914160,Peak free concentration at 50 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,0,=,,Activity,ug ml-1,,0.12,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,0.12
189187,,,1869723,[],CHEMBL914162,Peak free concentration at 250 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,0,=,,Activity,ug ml-1,,0.51,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,0.51
189188,,,1869724,[],CHEMBL914163,Peak free concentration at 320 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,0,=,,Activity,ug ml-1,,0.62,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,0.62
189189,,,1869736,[],CHEMBL914730,Peak free concentration at 100 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,0,=,,Activity,ug ml-1,,0.23,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,0.23
189190,,,1869737,[],CHEMBL914156,Peak free concentration at 150 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,0,=,,Activity,ug ml-1,,0.31,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,0.31
189191,,,1869799,[],CHEMBL914171,Half life at 150 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,634947,=,1,1,=,,T1/2,hr,,7.5,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,7.5
189192,,,1869805,[],CHEMBL914170,Half life at 100 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,634947,=,1,1,=,,T1/2,hr,,8.22,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,8.22
189193,,,1869820,[],CHEMBL914174,Half life at 50 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,634947,=,1,1,=,,T1/2,hr,,7.45,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,7.45
189194,,,1869822,[],CHEMBL914175,Half life at 75 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,634947,=,1,1,=,,T1/2,hr,,7.19,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,7.19
189195,,,1869829,[],CHEMBL914176,Half life at 250 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,634947,=,1,1,=,,T1/2,hr,,7.22,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,7.22
189196,,,1869836,[],CHEMBL914177,Half life at 320 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,634947,=,1,1,=,,T1/2,hr,,7.58,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,7.58
189197,,,1869971,[],CHEMBL915093,Bactericidal activity against Staphylococcus aureus ATCC 49619 with parC S79Y mutation at fAUC/MIC of 37 after 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
189198,,,1869972,[],CHEMBL915094,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 50.5 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.03
189199,,,1869973,[],CHEMBL915091,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 37 after 24 to 48 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.03
189200,,,1869974,[],CHEMBL915092,Bactericidal activity against Staphylococcus aureus ATCC 49619 with parC S79Y mutation at fAUC/MIC of 37 after 72 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
189201,,,1869975,[],CHEMBL915095,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 65.3 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.03
189202,,,1869976,[],CHEMBL915096,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 78 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.03
189203,,,1869977,[],CHEMBL915097,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 119 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.03
189204,,,1869978,[],CHEMBL915098,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 146 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.03
189205,,,1869979,[],CHEMBL915099,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 34 after 24 to 48 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.03
189206,,,1869980,[],CHEMBL915100,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S79Y, S52G, N91D mutation and gyrA S114G mutation at fAUC/MIC of 34 after 72 to 96 hrs in pharmacodynamic model",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.125
189207,,,1869981,[],CHEMBL915101,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 51.3 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.03
189208,,,1869982,[],CHEMBL915102,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 60.2 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.03
189209,,,1870017,[],CHEMBL914153,Susceptibility of Streptococcus pneumoniae ATCC 49619 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.025
189210,,,1870020,[],CHEMBL914732,Susceptibility of Streptococcus pneumoniae BSP-2443 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634947,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.025
189211,,Not Active,1870038,[],CHEMBL916090,Effect on efflux-mediatated resistance of Staphylococcus aureus ATCC 49619 mutant,F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,634947,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
189212,,,1870053,[],CHEMBL914192,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 50 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,634947,=,1,0,=,,fAUC/MIC,,,37.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,37.0
189213,,,1870055,[],CHEMBL915664,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 75 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,634947,=,1,0,=,,fAUC/MIC,,,50.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,50.5
189214,,,1870058,[],CHEMBL914187,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 100 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,634947,=,1,0,=,,fAUC/MIC,,,65.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,65.3
189215,,,1870067,[],CHEMBL915676,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 50 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,634947,=,1,0,=,,fAUC/MIC,,,34.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,34.0
189216,,,1870068,[],CHEMBL915677,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 75 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,634947,=,1,0,=,,fAUC/MIC,,,51.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,51.3
189217,,,1870069,[],CHEMBL915678,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 100 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,634947,=,1,0,=,,fAUC/MIC,,,69.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,69.2
189218,,,1870089,[],CHEMBL915665,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 250 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,634947,=,1,0,=,,fAUC/MIC,,,119.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,119.0
189219,,,1906098,[],CHEMBL888555,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 04-4 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145415,Bioorg Med Chem Lett,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,644088,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.004
189220,,,1906112,[],CHEMBL888556,Antibacterial activity against methicillin-resistant Staphylococcus aureus 05-3 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145415,Bioorg Med Chem Lett,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,644088,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.004
189221,,,1906131,[],CHEMBL888557,Antibacterial activity against Streptococcus pneumoniae 05-9 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145415,Bioorg Med Chem Lett,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,644088,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.004
189222,,,1906166,[],CHEMBL888559,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145415,Bioorg Med Chem Lett,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,644088,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
189223,,,1906183,[],CHEMBL888560,Antibacterial activity against Klebsiella pneumoniae 05-4 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145415,Bioorg Med Chem Lett,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,644088,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.125
189224,,,1906200,[],CHEMBL888561,Antibacterial activity against Pseudomonas aeruginosa ATCC 2785 after 18 to 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145415,Bioorg Med Chem Lett,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,644088,=,1,1,=,,MCC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MCC,ug ml-1,UO_0000274,,0.125
189225,,,1906216,[],CHEMBL888558,Antibacterial activity against Enterococcus faecalis 03-4 after 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1145415,Bioorg Med Chem Lett,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,644088,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.004
189226,,,2059987,[],CHEMBL926687,Oral bioavailability in human,A,,,BAO_0003042,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1141299,Bioorg Med Chem,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,684150,=,1,1,=,,F,%,,71.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F,%,UO_0000187,,71.0
189227,,Active,2154993,[],CHEMBL930275,"Elevation in glycogen level in fasting BALB/c mouse at 4.57 mg/kg, ip after 3 hrs",F,,,BAO_0000375,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1142395,J Med Chem,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,695909,,1,0,,,Activity,,,,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Activity,,,,
189228,,,2348375,[],CHEMBL957952,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
189229,,,2348376,[],CHEMBL957953,Antibacterial activity against Staphylococcus aureus ACH-0204 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
189230,,,2348377,[],CHEMBL957954,Antibacterial activity against Staphylococcus aureus ACH-0206 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
189231,,,2348378,[],CHEMBL957955,Antibacterial activity against Staphylococcus aureus ACH-0221 isolate with gyrA Ser84Leu mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
189232,,,2348379,[],CHEMBL957956,Antibacterial activity against Staphylococcus aureus ACH-0216 isolate with grlA Ser80Phe mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
189233,,,2348380,[],CHEMBL957957,Antibacterial activity against Staphylococcus aureus ACH-0218 isolate with grlA Glu84Lys mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
189234,,,2348381,[],CHEMBL957958,Antibacterial activity against Staphylococcus aureus ACH-0126 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189235,,,2348382,[],CHEMBL957959,Antibacterial activity against Staphylococcus aureus ACH-0210 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189236,,,2348383,[],CHEMBL957960,"Antibacterial activity against Staphylococcus aureus ACH-0186 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189237,,,2348384,[],CHEMBL957961,"Antibacterial activity against Staphylococcus aureus ACH-0192 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
189238,,,2348385,[],CHEMBL957962,"Antibacterial activity against Staphylococcus aureus ACH-0203 isolate with gyrA Ser84Leu and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
189239,,,2348386,[],CHEMBL957963,"Antibacterial activity against Staphylococcus aureus ACH-0129 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
189240,,,2348387,[],CHEMBL957964,"Antibacterial activity against Staphylococcus aureus ACH-0129 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
189241,,,2348388,[],CHEMBL954764,"Antibacterial activity against Staphylococcus aureus ACH-0201 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
189242,,,2348389,[],CHEMBL954765,"Antibacterial activity against Staphylococcus aureus ACH-0141 isolate with gyrA Ser84Leu, Glu88Val and grlA Ser80Phe, Ala116Val mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189243,,,2348390,[],CHEMBL957214,Antibacterial activity against Staphylococcus aureus ATCC 33591 isolate after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
189244,,,2348391,[],CHEMBL957215,Antibacterial activity against Staphylococcus aureus NY2746 isolate with gyrA Ser84Leu and grlA Ser80Phe mutant after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
189245,,,2348392,[],CHEMBL957216,"Antibacterial activity against Staphylococcus aureus ATCC 700699 isolate with gyrA Ser84Leu, Glu409Lys and grlA Ser80Phe mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189246,,,2348393,[],CHEMBL957217,"Antibacterial activity against Staphylococcus aureus BSA643 isolate with gyrA Ser84Leu and grlA Ser80Tyr, Glu84Gly mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
189247,,,2348394,[],CHEMBL957218,"Antibacterial activity against Staphylococcus aureus BSA678 isolate with gyrA Ser84Leu, Ser85Pro and grlA Ser80Phe, Glu84Gly mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
189248,,,2348395,[],CHEMBL957219,"Antibacterial activity against Staphylococcus aureus ACH-0231 isolate with gyrA Ser84Leu, Glu88Lys and grlA Ser80Tyr, Glu84Gly mutant after 24 hrs by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793283,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
189249,,,2348448,[],CHEMBL957238,Inhibition of Staphylococcus aureus wild-type DNA gyrase supercoiling activity assessed as effect on conversion of relaxed pBR322 DNA to supercoiled form,B,,,BAO_0000190,BAO_0000223,protein complex format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,"{'bei': '13.49', 'le': '0.26', 'lle': '4.28', 'sei': '4.27'}",CHEMBL430,GEMIFLOXACIN,CHEMBL430,5.25,1,http://www.openphacts.org/units/Nanomolar,793283,=,1,1,=,,IC50,nM,,5600.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,5.6
189250,,,2348449,[],CHEMBL957239,Inhibition of Staphylococcus aureus DNA gyrase gyrA S84L mutant supercoiling activity assessed as effect on conversion of relaxed pBR322 DNA to supercoiled form,B,P20831,S84L,BAO_0000190,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,793283,>,1,1,>,,IC50,nM,,300000.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,,IC50,uM,UO_0000065,,300.0
189251,,,2348450,[],CHEMBL957240,Inhibition of Staphylococcus aureus wild-type topoisomerase 4 decatenation activity assessed as unlinking of DNA microcircles from kinetoplast DNA,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,6.4,0,http://www.openphacts.org/units/Nanomolar,793283,=,1,1,=,,IC50,nM,,400.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.4
189252,,,2348451,[],CHEMBL957241,Inhibition of Staphylococcus aureus wild-type topoisomerase 4 grlA S80F mutant decatenation activity assessed as unlinking of DNA microcircles from kinetoplast DNA,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1157373,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,5.01,0,http://www.openphacts.org/units/Nanomolar,793283,=,1,1,=,,IC50,nM,,9800.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,9.8
189253,,,2659502,[],CHEMBL1036286,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 14 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
189254,,,2659586,[],CHEMBL1051483,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
189255,,,2659587,[],CHEMBL1051473,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189256,,,2659588,[],CHEMBL1051468,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189257,,,2659589,[],CHEMBL1051460,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
189258,,,2659590,[],CHEMBL1062983,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
189259,,,2659591,[],CHEMBL1023504,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
189260,,,2659592,[],CHEMBL1023494,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
189261,,,2659593,[],CHEMBL1023488,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
189262,,,2659594,[],CHEMBL1036288,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189263,,,2659595,[],CHEMBL1036283,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3274 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
189264,,,2659596,[],CHEMBL1052242,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 37 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
189265,,,2659597,[],CHEMBL1052246,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3413 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
189266,,,2659825,[],CHEMBL1051478,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 25 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189267,,,2659826,[],CHEMBL1051477,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 21 passages with gemifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
189268,,,2659827,[],CHEMBL1051476,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 18 passages with levofloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189269,,,2659828,[],CHEMBL1051475,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 19 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
189270,,,2659829,[],CHEMBL1051470,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189271,,,2659830,[],CHEMBL1051469,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 after 35 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189272,,,2659831,[],CHEMBL1051464,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 15 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189273,,,2659832,[],CHEMBL1051462,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 29 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189274,,,2659833,[],CHEMBL1051461,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 49 passages with clindamycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189275,,,2659834,[],CHEMBL1062986,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189276,,,2659835,[],CHEMBL1062985,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 26 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189277,,,2659836,[],CHEMBL1062984,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 38 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
189278,,,2659837,[],CHEMBL1062979,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189279,,,2659838,[],CHEMBL1062978,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 44 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189280,,,2659839,[],CHEMBL1023505,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 50 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189281,,,2659840,[],CHEMBL1023498,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 29 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189282,,,2659841,[],CHEMBL1023497,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 33 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189283,,,2659842,[],CHEMBL1023496,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 41 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189284,,,2659843,[],CHEMBL1023495,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 20 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189285,,,2659844,[],CHEMBL1023490,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 14 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189286,,,2659845,[],CHEMBL1052241,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 14 passages with clindamycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189287,,,2659846,[],CHEMBL1023489,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 49 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189288,,,2659847,[],CHEMBL1023485,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
189289,,,2659848,[],CHEMBL1023484,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 after 50 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189290,,,2659849,[],CHEMBL1036285,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 20 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189291,,,2659850,[],CHEMBL1036284,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 14 passages with gemifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
189292,,,2659851,[],CHEMBL1036280,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3274 after 48 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189293,,,2659852,[],CHEMBL1052245,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 37 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189294,,,2659853,[],CHEMBL1052249,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3413 after 30 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189295,,,2660228,[],CHEMBL1051481,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 21 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189296,,,2660235,[],CHEMBL1051474,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189297,,,2660243,[],CHEMBL1051467,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189298,,,2660253,[],CHEMBL1051459,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189299,,,2660261,[],CHEMBL1062982,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189300,,,2660271,[],CHEMBL1023503,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189301,,,2660280,[],CHEMBL1023493,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189302,,,2660286,[],CHEMBL1023487,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189303,,,2660302,[],CHEMBL1036282,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3274 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189304,,,2660308,[],CHEMBL1052243,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 37 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
189305,,,2660316,[],CHEMBL1052247,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3413 after 50 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818308,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
189306,,,2674029,[],CHEMBL1026149,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 after 50 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
189307,,,2674034,[],CHEMBL1026148,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 5048 expressing mefA after 50 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
189308,,,2674045,[],CHEMBL1026146,Antibacterial activity against penicillin- and quinolone-susceptible Streptococcus pneumoniae HMC 5055 expressing mefA after 50 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189309,,,2674051,[],CHEMBL1026145,"Antibacterial activity against penicillin-, quinolone-resistant Streptococcus pneumoniae HMC 1541 harboring mutation in L4 protein by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189310,,,2674057,[],CHEMBL1026144,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189311,,,2674063,[],CHEMBL1026143,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189312,,,2674069,[],CHEMBL1026142,"Antibacterial activity against penicillin-, quinolone-resistant and macrolide-susceptible Streptococcus pneumoniae HMC 1058 harboring S79F, K137N mutation in quinolone-resistant determining regions of ParC gene and 460V mutation in QRDR of ParE gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
189313,,,2674075,[],CHEMBL1031971,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 5048 expressing mefA by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189314,,,2674081,[],CHEMBL1031970,Antibacterial activity against quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 441 expressing ermB by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
189315,,,2674087,[],CHEMBL1031969,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189316,,,2674093,[],CHEMBL1031968,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189317,,,2674099,[],CHEMBL1031967,Antibacterial activity against penicillin- and quinolone-susceptible Streptococcus pneumoniae HMC 5055 expressing mefA by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189318,,,2674105,[],CHEMBL1031966,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189319,,,2674111,[],CHEMBL1031965,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189320,,,2674117,[],CHEMBL1031964,"Antibacterial activity against penicillin-susceptible, quinolone-resistant Streptococcus pneumoniae 1072 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189321,,,2674122,[],CHEMBL1031142,"Antibacterial activity against Streptococcus pneumoniae HMC 1068 harboring E85K mutation in quinolone-resistant determining regions of GyrA gene, S79Y, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, levofloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189322,,,2674128,[],CHEMBL1031141,"Antibacterial activity against Streptococcus pneumoniae HMC 1062 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189323,,,2674134,[],CHEMBL1031140,"Antibacterial activity against Streptococcus pneumoniae HMC 4026 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189324,,,2674140,[],CHEMBL1031139,"Antibacterial activity against Streptococcus pneumoniae HMC 2536 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
189325,,,2674146,[],CHEMBL1031138,"Antibacterial activity against Streptococcus pneumoniae HMC 2527 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189326,,,2674152,[],CHEMBL1031137,"Antibacterial activity against Streptococcus pneumoniae HMC 1541 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189327,,,2674158,[],CHEMBL1031136,"Antibacterial activity against Streptococcus pneumoniae HMC 1156 harboring S81F and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.1
189328,,,2674164,[],CHEMBL1031135,"Antibacterial activity against Streptococcus pneumoniae HMC 1139 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189329,,,2674170,[],CHEMBL1026129,"Antibacterial activity against Streptococcus pneumoniae HMC 1078 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189330,,,2674176,[],CHEMBL1026128,Antibacterial activity against Streptococcus pneumoniae HMC 1077 harboring S81Y and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189331,,,2674182,[],CHEMBL1026127,"Antibacterial activity against Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189332,,,2674188,[],CHEMBL1026126,"Antibacterial activity against Streptococcus pneumoniae HMC 1072 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189333,,,2674194,[],CHEMBL1026125,"Antibacterial activity against Streptococcus pneumoniae HMC 1071 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene and S79F, K137N mutation in QRDR of ParC gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189334,,,2674200,[],CHEMBL1026124,"Antibacterial activity against Streptococcus pneumoniae HMC 1059 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460N mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189335,,,2674206,[],CHEMBL1025290,"Antibacterial activity against Streptococcus pneumoniae HMC 1055 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189336,,,2674212,[],CHEMBL1025289,Antibacterial activity against Streptococcus pneumoniae HMC 5041 harboring S81F and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189337,,,2674218,[],CHEMBL1025288,"Antibacterial activity against Streptococcus pneumoniae HMC 2538 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, levofloxacin, gatifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189338,,,2674224,[],CHEMBL1025287,"Antibacterial activity against Streptococcus pneumoniae HMC 1150 harboring S81C mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189339,,,2674230,[],CHEMBL1025286,"Antibacterial activity against Streptococcus pneumoniae HMC 1147 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189340,,,2674236,[],CHEMBL1025285,"Antibacterial activity against Streptococcus pneumoniae HMC 1146 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, and D435N mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189341,,,2674242,[],CHEMBL1025284,"Antibacterial activity against Streptococcus pneumoniae HMC 1076 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189342,,,2674248,[],CHEMBL1025283,"Antibacterial activity against Streptococcus pneumoniae HMC 1073 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
189343,,,2674254,[],CHEMBL1025282,"Antibacterial activity against Streptococcus pneumoniae HMC 1070 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189344,,,2674260,[],CHEMBL1025281,"Antibacterial activity against Streptococcus pneumoniae HMC 1066 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189345,,,2674266,[],CHEMBL1025280,"Antibacterial activity against Streptococcus pneumoniae HMC 1060 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189346,,,2674925,[],CHEMBL1025279,"Antibacterial activity against Streptococcus pneumoniae HMC 1058 harboring S79F, K137N mutation in quinolone-resistant determining regions of ParC gene and 460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
189347,,,2674931,[],CHEMBL1031123,"Antibacterial activity against Streptococcus pneumoniae HMC 1151 harboring D83N, K137N mutation in quinolone-resistant determining regions of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189348,,,2674937,[],CHEMBL1031122,"Antibacterial activity against Streptococcus pneumoniae HMC 1149 harboring S81F and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189349,,,2674945,[],CHEMBL1031121,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
189350,,,2674954,[],CHEMBL1031121,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
189351,,,2674963,[],CHEMBL1031120,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.06
189352,,,2674972,[],CHEMBL1031120,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
189353,,,2674981,[],CHEMBL1031119,Antibacterial activity against azithromycin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.06
189354,,,2674990,[],CHEMBL1031119,Antibacterial activity against azithromycin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
189355,,,2674999,[],CHEMBL1031118,Antibacterial activity against azithromycin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
189356,,,2675008,[],CHEMBL1031118,Antibacterial activity against azithromycin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
189357,,,2675017,[],CHEMBL1031117,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
189358,,,2675026,[],CHEMBL1031117,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
189359,,,2675035,[],CHEMBL1031116,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.06
189360,,,2675044,[],CHEMBL1031116,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
189361,,,2675053,[],CHEMBL1031115,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.12
189362,,,2675059,[],CHEMBL1026151,Antibacterial activity against Streptococcus pneumoniae HMC 3041 after 50 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189363,,,2675063,[],CHEMBL1031115,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
189364,,,2675073,[],CHEMBL1026152,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB after 50 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189365,,,2675082,[],CHEMBL1026154,"Antibacterial activity against penicillin-susceptible, quinolone-resistant Streptococcus pneumoniae HMC 1072 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 50 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189366,,,2675093,[],CHEMBL1026156,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 34 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189367,,,2675099,[],CHEMBL1026974,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 99 harboring S81Y and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively after 41 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189368,,,2675105,[],CHEMBL1026975,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S81Y and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively after 42 passages with levofloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189369,,,2675111,[],CHEMBL1026976,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene after 22 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189370,,,2675117,[],CHEMBL1026977,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 harboring S79Y mutation in quinolone-resistant determining regions of ParC gene after 34 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189371,,,2675123,[],CHEMBL1026978,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 28 passages with DC-159a measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189372,,,2675129,[],CHEMBL1026979,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 36 passages with moxifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
189373,,,2675135,[],CHEMBL1026980,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 49 passages with DC-159a measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
189374,,,2675141,[],CHEMBL1026981,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene and I460V, D435N mutation in QRDR of ParE gene after 46 passages with gatifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
189375,,,2675147,[],CHEMBL1029503,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring I460V mutation in QRDR of ParE gene after 41 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
189376,,,2675153,[],CHEMBL1031996,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F, E85K mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 27 passages with gemifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
189377,,,2675161,[],CHEMBL1031999,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 228 expressing ermB and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 38 passages with gatifloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
189378,,,2675167,[],CHEMBL1032774,"Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA and harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 44 passages with levofloxacin measured after 10 daily antibiotic-free subculturing by multi-step resistance selection technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189379,,,2675169,[],CHEMBL1032776,"Antibacterial activity against penicillin-, macrolide-susceptible and quinolone-resistant Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene after 27 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
189380,,,2675170,[],CHEMBL1032777,Antibacterial activity against penicillin-resistant and quinolone-susceptible Streptococcus pneumoniae HMC 3583 expressing mefA after 41 passages by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189381,,,2675179,[],CHEMBL1032786,"Antibacterial activity against macrolide-, quinolone-susceptible and penicillin-intermediate Streptococcus pneumoniae HMC 100 after 42 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189382,,,2675181,[],CHEMBL1032787,"Antibacterial activity against penicillin-, macrolide- and quinolone-susceptible Streptococcus pneumoniae HMC 63 after 34 passages by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819268,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189383,,,2711143,[],CHEMBL1053371,"Antibacterial activity against Escherichia coli 1608 containing gyrA L83, L87 mutants assessed as increase in MIC by Etest relative to MIC for wild type Escherichia coli 1609",F,,,BAO_0000193,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,826419,=,1,0,=,,Ratio,,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,5.0
189384,,,2711153,[],CHEMBL1053372,"Antibacterial activity against Escherichia coli 1596 containing gyrA L83 and parC I80, G84 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli 1608 containing gyrA mutant",F,,,BAO_0000193,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,826419,=,1,0,=,,Ratio,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,1.0
189385,,,2711156,[],CHEMBL1053373,Antibacterial activity against Escherichia coli 1596 containing parC K84 mutant assessed as decrease in MIC by Etest relative to MIC for Escherichia coli 1608 containing gyrA mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826419,=,1,1,=,,MIC,ug.mL-1,,0.007,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.007
189386,,,2711163,[],CHEMBL1053374,"Antibacterial activity against Escherichia coli SKM9 containing gyrA L83, Y87 and parC L80 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli 1596 containing gyrA L83 and parC I80 mutants",F,,,BAO_0000193,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,826419,=,1,0,=,,Ratio,,,9.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,9.0
189387,,,2911605,[],CHEMBL1041241,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1154061,Eur J Med Chem,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847740,<,1,1,<,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
189388,,,2911624,[],CHEMBL1041242,Antibacterial activity against methicillin-resistant Staphylococcus aureus 05-3 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1154061,Eur J Med Chem,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847740,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189389,,,2911643,[],CHEMBL1041243,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1154061,Eur J Med Chem,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847740,<,1,1,<,,MIC,ug.mL-1,,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.03
189390,,,2911662,[],CHEMBL1041244,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 05-1 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1154061,Eur J Med Chem,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847740,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
189391,,,2911681,[],CHEMBL1041245,Antibacterial activity against Streptococcus pneumoniae 97100 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1154061,Eur J Med Chem,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847740,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
189392,,,2912044,[],CHEMBL1041246,Antibacterial activity against Streptococcus pyogenes 9619 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1154061,Eur J Med Chem,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847740,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,2.0
189393,,,2912063,[],CHEMBL1041247,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1154061,Eur J Med Chem,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847740,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.06
189394,,,2912082,[],CHEMBL1041248,Antibacterial activity against Escherichia coli 26 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1154061,Eur J Med Chem,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847740,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
189395,,,2912101,[],CHEMBL1041249,Antibacterial activity against Klebsiella pneumoniae 7 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1154061,Eur J Med Chem,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847740,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
189396,,,2912120,[],CHEMBL1041250,Antibacterial activity against Pseudomonas aeruginosa 17 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1154061,Eur J Med Chem,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847740,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
189397,,,2912139,[],CHEMBL1041251,Antibacterial activity against Shigella sonnei 51592 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1154061,Eur J Med Chem,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847740,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,MIC,ug ml-1,UO_0000274,,0.06
189398,,,2912158,[],CHEMBL1041252,Antibacterial activity against Enterobacter cloacae 45301 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1154061,Eur J Med Chem,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847740,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.06
189399,,,3383900,[],CHEMBL1220798,Antimicrobial activity against mild ciprofloxacin-resistant Streptococcus pyogenes at 10 ug by disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Millimeter,930663,=,1,1,=,,IZ,mm,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,IZ,mm,UO_0000016,,0.0
189400,,,3383901,[],CHEMBL1220799,Antimicrobial activity against strong ciprofloxacin-resistant Streptococcus pyogenes at 10 ug by disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Millimeter,930663,=,1,1,=,,IZ,mm,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,IZ,mm,UO_0000016,,0.0
189401,,,3383902,[],CHEMBL1220800,Antimicrobial activity against ciprofloxacin-susceptible Streptococcus pyogenes harboring Asp91/Asn mutation in parC gene at 10 ug by disk diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Millimeter,930663,=,1,1,=,,IZ,mm,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,IZ,mm,UO_0000016,,0.0
189402,,,3389540,[],CHEMBL1216830,Antibacterial activity against Streptococcus pneumoniae 1151 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,8.0
189403,,,3389543,[],CHEMBL1216829,Antibacterial activity against Streptococcus pneumoniae 1149 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,>,1,0,>,,Activity,ug ml-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,8.0
189404,,,3389546,[],CHEMBL1216828,Antibacterial activity against Streptococcus pneumoniae 1072 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,8.0
189405,,,3389549,[],CHEMBL1216827,Antibacterial activity against Streptococcus pneumoniae 1135 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189406,,,3389552,[],CHEMBL1216826,Antibacterial activity against Streptococcus pneumoniae 1065 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
189407,,,3389555,[],CHEMBL1216825,Antibacterial activity against Streptococcus pneumoniae 1058 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
189408,,,3389558,[],CHEMBL1216824,Antibacterial activity against Streptococcus pneumoniae 3321 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
189409,,,3389561,[],CHEMBL1216823,Antibacterial activity against Streptococcus pneumoniae 1151 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189410,,,3389564,[],CHEMBL1216822,Antibacterial activity against Streptococcus pneumoniae 1149 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189411,,,3389567,[],CHEMBL1216821,Antibacterial activity against Streptococcus pneumoniae 1072 by standard agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
189412,,,3389571,[],CHEMBL1216820,Ratio of 90% mutant prevention concentration to MIC90 in Streptococcus pneumoniae ATCC 49619,F,,,BAO_0000193,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,930686,=,1,0,=,,Ratio,,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,,4.0
189413,,,3389574,[],CHEMBL1216819,Ratio of 50% mutant prevention concentration to MIC50 in Streptococcus pneumoniae ATCC 49619,F,,,BAO_0000193,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,930686,=,1,0,=,,Ratio,,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Ratio,,,,4.0
189414,,,3389577,[],CHEMBL1216818,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 assessed as 90% mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,4.0
189415,,,3389580,[],CHEMBL1216817,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 assessed as 50% mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,0,=,,Activity,ug ml-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,0.5
189416,,,3389583,[],CHEMBL1216816,Antibacterial activity against Streptococcus pneumoniae ATCC 49619,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
189417,,,3389586,[],CHEMBL1216816,Antibacterial activity against Streptococcus pneumoniae ATCC 49619,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.125
189418,,,3389587,[],CHEMBL1216831,Antibacterial activity against Streptococcus pneumoniae 3321 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,0,=,,Activity,ug ml-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,2.0
189419,,,3389590,[],CHEMBL1216832,Antibacterial activity against Streptococcus pneumoniae 1058 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,0,=,,Activity,ug ml-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,1.0
189420,,,3389593,[],CHEMBL1216833,Antibacterial activity against Streptococcus pneumoniae 1065 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,4.0
189421,,,3389596,[],CHEMBL1216834,Antibacterial activity against Streptococcus pneumoniae 1135 assessed as mutant prevention concentration by standard agar dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212804,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930686,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,4.0
189422,,,3397711,[],CHEMBL1220793,Antimicrobial activity against strong ciprofloxacin-resistant Streptococcus pyogenes by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930663,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,1.0
189423,,,3397718,[],CHEMBL1220794,Antimicrobial activity against mild ciprofloxacin-resistant Streptococcus pyogenes by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930663,<=,1,1,<=,,MIC50,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.25
189424,,,3397725,[],CHEMBL1220794,Antimicrobial activity against mild ciprofloxacin-resistant Streptococcus pyogenes by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930663,<=,1,1,<=,,MIC90,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.25
189425,,,3397732,[],CHEMBL1220795,Antimicrobial activity against ciprofloxacin-susceptible Streptococcus pyogenes harboring Asp91/Asn mutation in parC gene by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930663,<=,1,1,<=,,MIC50,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.25
189426,,,3397739,[],CHEMBL1220795,Antimicrobial activity against ciprofloxacin-susceptible Streptococcus pyogenes harboring Asp91/Asn mutation in parC gene by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930663,<=,1,1,<=,,MIC90,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.25
189427,,,3402058,[],CHEMBL1219409,Antimicrobial activity against Bacillus subtilis ATCC 6633 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933299,=,1,1,=,,MIC,ug.mL-1,,0.007,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.007
189428,,,3402059,[],CHEMBL1219410,Antimicrobial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933299,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.015
189429,,,3402060,[],CHEMBL1219408,Antimicrobial activity against quinolone and penicillin-resistant Staphylococcus aureus SAR72 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933299,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.0
189430,,,3402061,[],CHEMBL1219412,Antimicrobial activity against quinolone and penicillin-resistant Staphylococcus aureus SAR4790 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933299,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
189431,,,3402062,[],CHEMBL1219411,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933299,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.015
189432,,,3402063,[],CHEMBL1219413,Antimicrobial activity against quinolone and penicillin-resistant Staphylococcus epidermidis SER after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933299,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,50.0
189433,,,3402064,[],CHEMBL1219414,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933299,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.3
189434,,,3402065,[],CHEMBL1219415,Antimicrobial activity against quinolone and penicillin-resistant Acinetobacter baumannii after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933299,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,100.0
189435,,,3402066,[],CHEMBL1219416,Antimicrobial activity against Escherichia coli ATCC 8739 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933299,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
189436,,,3402067,[],CHEMBL1219417,Antimicrobial activity against quinolone and penicillin-resistant Escherichia coli after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933299,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,50.0
189437,,,3402068,[],CHEMBL1219418,Antimicrobial activity against Haemophilus influenzae ATCC 19418 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933299,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.015
189438,,,3402069,[],CHEMBL1219419,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933299,=,1,1,=,,MIC,ug.mL-1,,0.07,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.07
189439,,,3402070,[],CHEMBL1219509,Antimicrobial activity against quinolone and penicillin-resistant Pseudomonas aeruginosa after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1212890,Bioorg Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,933299,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,100.0
189440,,,3478584,[],CHEMBL1266054,Antimicrobial activity against beta-lactam resistant Streptococcus pneumoniae clinical isolate by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255371,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960663,<=,1,1,<=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
189441,,,3478585,[],CHEMBL1266054,Antimicrobial activity against beta-lactam resistant Streptococcus pneumoniae clinical isolate by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255371,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960663,<=,1,1,<=,,MIC90,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.03
189442,,,3478589,[],CHEMBL1266054,Antimicrobial activity against beta-lactam resistant Streptococcus pneumoniae clinical isolate by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255371,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960663,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189443,,,3478605,[],CHEMBL1266059,Antimicrobial activity against Streptococcus pneumoniae isolated from meningitis patient assessed as percent susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255371,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,960663,=,1,0,=,,Activity,%,,98.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,98.9
189444,,,3478610,[],CHEMBL1266060,Antimicrobial activity against Streptococcus pneumoniae isolated from meningitis patient assessed as percent resistant isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255371,Antimicrob Agents Chemother,2008.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,960663,=,1,0,=,,Activity,%,,1.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,1.1
189445,,,3488687,[],CHEMBL1265251,Antibacterial activity against Citrobacter freundii by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC90,ug ml-1,UO_0000274,,4.0
189446,,,3488688,[],CHEMBL1265251,Antibacterial activity against Citrobacter freundii by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC50,ug ml-1,UO_0000274,,1.0
189447,,,3488689,[],CHEMBL1265251,Antibacterial activity against Citrobacter freundii by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.015
189448,,,3488711,[],CHEMBL1265249,Antibacterial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,0.25
189449,,,3488712,[],CHEMBL1265249,Antibacterial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC50,ug ml-1,UO_0000274,,0.12
189450,,,3488713,[],CHEMBL1265249,Antibacterial activity against Proteus mirabilis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.06
189451,,,3488723,[],CHEMBL1265248,Antibacterial activity against Serratia marcescens by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC90,ug ml-1,UO_0000274,,0.5
189452,,,3488724,[],CHEMBL1265248,Antibacterial activity against Serratia marcescens by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC50,ug ml-1,UO_0000274,,0.25
189453,,,3488725,[],CHEMBL1265248,Antibacterial activity against Serratia marcescens by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.015
189454,,,3488771,[],CHEMBL1265244,Antibacterial activity against ciprofloxacin-resistant Escherichia coli by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,64.0
189455,,,3488772,[],CHEMBL1265244,Antibacterial activity against ciprofloxacin-resistant Escherichia coli by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,32.0
189456,,,3488773,[],CHEMBL1265244,Antibacterial activity against ciprofloxacin-resistant Escherichia coli by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
189457,,,3488798,[],CHEMBL1265242,Antibacterial activity against Moraxella catarrhalis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,<=,1,1,<=,,MIC90,ug.mL-1,,0.015,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.015
189458,,,3488799,[],CHEMBL1265242,Antibacterial activity against Moraxella catarrhalis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,<=,1,1,<=,,MIC50,ug.mL-1,,0.015,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC50,ug ml-1,UO_0000274,,0.015
189459,,,3488800,[],CHEMBL1265242,Antibacterial activity against Moraxella catarrhalis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.015
189460,,,3488810,[],CHEMBL1265241,Antibacterial activity against Haemophilus influenzae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC90,ug.mL-1,,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.008
189461,,,3488811,[],CHEMBL1265241,Antibacterial activity against Haemophilus influenzae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,<=,1,1,<=,,MIC50,ug.mL-1,,0.004,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,0.004
189462,,,3488812,[],CHEMBL1265241,Antibacterial activity against Haemophilus influenzae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.002
189463,,,3488966,[],CHEMBL1265228,Antibacterial activity against ciprofloxacin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
189464,,,3488967,[],CHEMBL1265228,Antibacterial activity against ciprofloxacin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,4.0
189465,,,3488968,[],CHEMBL1265228,Antibacterial activity against ciprofloxacin-resistant Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
189466,,,3488987,[],CHEMBL1265227,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
189467,,,3488988,[],CHEMBL1265227,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
189468,,,3488989,[],CHEMBL1265227,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959896,<=,1,1,<=,,MIC,ug.mL-1,,0.004,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.004
189469,,,3591088,[],CHEMBL1291910,Antibacterial activity against Staphylococcus aureus ATCC 259223 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
189470,,,3591131,[],CHEMBL1291911,Antibacterial activity against methicillin-resistant Staphylococcus aureus 08-1 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
189471,,,3591174,[],CHEMBL1291912,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 08-2 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
189472,,,3591217,[],CHEMBL1292563,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 09-2 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
189473,,,3591260,[],CHEMBL1292564,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 09-3 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
189474,,,3591303,[],CHEMBL1292565,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 09-4 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
189475,,,3591721,[],CHEMBL1292566,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 09-3 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
189476,,,3591764,[],CHEMBL1292567,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 09-6 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
189477,,,3591807,[],CHEMBL1292568,Antibacterial activity against Streptococcus pneumoniae 08-2 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
189478,,,3591850,[],CHEMBL1292569,Antibacterial activity against Streptococcus pneumoniae 08-4 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189479,,,3591893,[],CHEMBL1292570,Antibacterial activity against Enterococcus faecium 08-2 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,16.0
189480,,,3591936,[],CHEMBL1292571,Antibacterial activity against Enterococcus faecium 08-7 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
189481,,,3591979,[],CHEMBL1292572,Antibacterial activity against Enterococcus faecalis 08-10 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,16.0
189482,,,3592022,[],CHEMBL1292573,Antibacterial activity against Enterococcus faecalis 08-12 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,16.0
189483,,,3592065,[],CHEMBL1292574,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
189484,,,3592484,[],CHEMBL1292575,Antibacterial activity against Escherichia coli 08-21 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
189485,,,3592527,[],CHEMBL1292576,Antibacterial activity against Escherichia coli 08-22 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
189486,,,3592570,[],CHEMBL1292577,Antibacterial activity against Klebsiella pneumoniae 09-21 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
189487,,,3592613,[],CHEMBL1292578,Antibacterial activity against Klebsiella pneumoniae 09-22 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
189488,,,3592656,[],CHEMBL1292579,Antibacterial activity against Klebsiella pneumoniae 09-23 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
189489,,,3592699,[],CHEMBL1292580,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
189490,,,3592742,[],CHEMBL1292581,Antibacterial activity against Pseudomonas aeruginosa 09-32 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
189491,,,3592785,[],CHEMBL1292582,Antibacterial activity against Pseudomonas aeruginosa 09-33 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
189492,,,3593174,[],CHEMBL1292583,Antibacterial activity against Pseudomonas aeruginosa 09-34 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
189493,,,3593217,[],CHEMBL1292584,Antibacterial activity against Pseudomonas aeruginosa 09-35 after 18 to 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1287651,Eur J Med Chem,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,974548,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
189494,,,5179129,[],CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322829,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.004
189495,,,5179138,[],CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322829,=,1,1,=,,MIC50,ug.mL-1,,0.032,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC50,ug ml-1,UO_0000274,,0.032
189496,,,5179147,[],CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322829,=,1,1,=,,MIC90,ug.mL-1,,0.125,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC90,ug ml-1,UO_0000274,,0.125
189497,,,5194871,[],CHEMBL1671526,Antibacterial activity against Streptococcus hemolyticus 1002 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329321,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,8.0
189498,,,5194892,[],CHEMBL1671527,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329321,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
189499,,,5194913,[],CHEMBL1671528,Antibacterial activity against Escherichia coli 10-02 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329321,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
189500,,,5194934,[],CHEMBL1671529,Antibacterial activity against Klebsiella pneumoniae 10-1 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329321,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
189501,,,5194955,[],CHEMBL1671530,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329321,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
189502,,,5194976,[],CHEMBL1671531,Antibacterial activity against Pseudomonas aeruginosa 10-1 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329321,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
189503,,,5206322,[],CHEMBL1671222,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329321,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
189504,,,5206343,[],CHEMBL1671223,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-04 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329321,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
189505,,,5206364,[],CHEMBL1671224,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-05 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329321,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189506,,,5206385,[],CHEMBL1671225,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 10-4 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329321,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
189507,,,5206406,[],CHEMBL1671226,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-5 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329321,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
189508,,,5206427,[],CHEMBL1671525,Antibacterial activity against Streptococcus pneumoniae 1001 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329321,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
189509,,,5214797,[],CHEMBL1676704,Antibacterial activity against 10'4 to 10'5 CFU Moraxella catarrhalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.008
189510,,,5214798,[],CHEMBL1676703,Antibacterial activity against 10'4 to 10'5 CFU Haemophilus influenzae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.008
189511,,,5214812,[],CHEMBL1676704,Antibacterial activity against 10'4 to 10'5 CFU Moraxella catarrhalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,<,1,1,<,,MIC50,ug.mL-1,,0.008,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC50,ug ml-1,UO_0000274,,0.008
189512,,,5214813,[],CHEMBL1676703,Antibacterial activity against 10'4 to 10'5 CFU Haemophilus influenzae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC50,ug.mL-1,,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,0.008
189513,,,5214827,[],CHEMBL1676704,Antibacterial activity against 10'4 to 10'5 CFU Moraxella catarrhalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,<,1,1,<,,MIC90,ug.mL-1,,0.008,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.008
189514,,,5214828,[],CHEMBL1676703,Antibacterial activity against 10'4 to 10'5 CFU Haemophilus influenzae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC90,ug.mL-1,,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.008
189515,,,5217672,[],CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
189516,,,5217680,[],CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.015
189517,,,5217688,[],CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.06
189518,,,5217696,[],CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
189519,,,5217704,[],CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug ml-1,UO_0000274,,0.008
189520,,,5217712,[],CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug ml-1,UO_0000274,,0.008
189521,,,5217720,[],CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
189522,,,5217728,[],CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,2.0
189523,,,5217736,[],CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,ug ml-1,UO_0000274,,0.015
189524,,,5217744,[],CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,ug ml-1,UO_0000274,,0.5
189525,,,5217752,[],CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
189526,,,5217760,[],CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,64.0
189527,,,5217768,[],CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,ug ml-1,UO_0000274,,0.5
189528,,,5217776,[],CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,ug ml-1,UO_0000274,,1.0
189529,,,5217784,[],CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.06
189530,,,5217792,[],CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.015
189531,,,5217800,[],CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.008
189532,,,5217808,[],CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.03
189533,,,5217816,[],CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC,ug ml-1,UO_0000274,,0.015
189534,,,5217824,[],CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.03
189535,,,5217832,[],CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,0.125
189536,,,5217840,[],CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,2.0
189537,,,5217848,[],CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC50,ug ml-1,UO_0000274,,0.5
189538,,,5217856,[],CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.06
189539,,,5217864,[],CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,4.0
189540,,,5217872,[],CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,16.0
189541,,,5217880,[],CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332736,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC90,ug ml-1,UO_0000274,,2.0
189542,,,6172603,[],CHEMBL1767999,Antimicrobial activity against Bacillus cereus ATCC 11778 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,0.07,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.07
189543,,,6172612,[],CHEMBL1768000,Antimicrobial activity against Bacillus megaterium ATCC 19213 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,0.0003,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,,MIC,ug ml-1,UO_0000274,,0.0003
189544,,,6172621,[],CHEMBL1768001,Antimicrobial activity against Bacillus subtilis ATCC 6633 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,0.007,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.007
189545,,,6172630,[],CHEMBL1768002,Antimicrobial activity against Bacillus thuringiensis var.kurstaki BGSC 4D1 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.015
189546,,,6172639,[],CHEMBL1768003,Antimicrobial activity against Staphylococcus aureus ATCC 6538 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.015
189547,,,6172648,[],CHEMBL1768004,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 72 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.0
189548,,,6172657,[],CHEMBL1768005,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 4790 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
189549,,,6172666,[],CHEMBL1768006,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.015
189550,,,6172675,[],CHEMBL1768007,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus epidermidis clinical isolate by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,50.0
189551,,,6172684,[],CHEMBL1768008,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.3
189552,,,6172693,[],CHEMBL1768009,Antimicrobial activity against quinilone-pencillin-resistant Acinetobacter baumannii clinical isolate by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,100.0
189553,,,6172702,[],CHEMBL1768010,Antimicrobial activity against Escherichia coli ATCC 8739 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
189554,,,6172711,[],CHEMBL1768011,Antimicrobial activity against quinilone-pencillin-resistant Escherichia coli clinical isolate by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,50.0
189555,,,6172720,[],CHEMBL1768012,Antimicrobial activity against Haemophilus influenzae ATCC 19418 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.015
189556,,,6172729,[],CHEMBL1768013,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,=,1,1,=,,MIC,ug.mL-1,,0.07,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.07
189557,,,6172738,[],CHEMBL1768014,Antimicrobial activity against Saccharomyces cerevisiae ATCC 9763 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,,100.0
189558,,,6172748,[],CHEMBL1768015,Antimicrobial activity against Candida tropicalis ATCC 1369 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL612870,Candida tropicalis,Candida tropicalis,5482.0,,,MIC,ug ml-1,UO_0000274,,100.0
189559,,,6173384,[],CHEMBL1768201,Antimicrobial activity against Aspergillus niger ATCC 6275 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1765022,Bioorg Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418182,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,,MIC,ug ml-1,UO_0000274,,100.0
189560,,,6184803,[],CHEMBL1775350,Inhibition of wild-type Staphylococcus aureus topoisomerase 4-mediated decatenation of kDNA after 30 mins by gel electrophoresis assay,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,6.4,0,http://www.openphacts.org/units/Nanomolar,1422186,=,1,1,=,,IC50,nM,,400.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.4
189561,,,6184810,[],CHEMBL1775351,Inhibition of wild-type Staphylococcus aureus DNA gyrase assessed as inhibition of supercoiling of pBR322 DNA after 60 min by gel electrophoresis assay,B,,,BAO_0000190,BAO_0000223,protein complex format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1772978,J Med Chem,2011.0,"{'bei': '13.49', 'le': '0.26', 'lle': '4.28', 'sei': '4.27'}",CHEMBL430,GEMIFLOXACIN,CHEMBL430,5.25,1,http://www.openphacts.org/units/Nanomolar,1422186,=,1,1,=,,IC50,nM,,5600.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,5.6
189562,,,6184817,[],CHEMBL1775357,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1422186,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
189563,,,6184824,[],CHEMBL1775519,Inhibition of Staphylococcus aureus topoisomerase 4 Ser80Phe mutant-mediated decatenation of kDNA after 30 mins by gel electrophoresis assay,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,5.01,0,http://www.openphacts.org/units/Nanomolar,1422186,=,1,1,=,,IC50,nM,,9800.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,9.8
189564,,,6184831,[],CHEMBL1775520,Inhibition of Staphylococcus aureus DNA gyrase Ser84Leu mutant assessed as inhibition of supercoiling of pBR322 DNA after 60 min by gel electrophoresis assay,B,P20831,S84L,BAO_0000190,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1772978,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,1422186,>,1,1,>,,IC50,nM,,200000.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,,IC50,uM,UO_0000065,,200.0
189565,,,6184832,[],CHEMBL1775348,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1422186,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
189566,,,6184833,[],CHEMBL1775353,Antibacterial activity against Escherichia coli ATCC25922 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1772978,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1422186,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
189567,,,6208971,[],CHEMBL1781603,Antibacterial activity against Staphylococcus aureus ATCC 13709,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
189568,,,6208972,[],CHEMBL1781602,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 08-49,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
189569,,,6208973,[],CHEMBL1781604,Antibacterial activity against methicillin-resistant Staphylococcus aureus 08-52,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
189570,,,6208974,[],CHEMBL1781605,Antibacterial activity against Staphylococcus epidermidis ATCC 12228,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
189571,,,6208975,[],CHEMBL1781606,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 08-17,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
189572,,,6208976,[],CHEMBL1781746,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 08-18,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.03
189573,,,6208977,[],CHEMBL1781747,Antibacterial activity against Streptococcus pneumoniae ATCC 6301,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
189574,,,6208978,[],CHEMBL1781748,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 08-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189575,,,6208979,[],CHEMBL1781749,Antibacterial activity against Enterococcus faecalis ATCC 51299,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.06
189576,,,6208980,[],CHEMBL1781750,Antibacterial activity against vancomycin-resistant Enterococcus faecalis EFL1004,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
189577,,,6208981,[],CHEMBL1781751,Antibacterial activity against Streptococcus pyogenes 556,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.125
189578,,,6208982,[],CHEMBL1781752,Antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
189579,,,6208983,[],CHEMBL1781753,Antibacterial activity against Extended spectrum beta-lactamase producing Escherichia coli 08-5,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
189580,,,6208984,[],CHEMBL1781754,Antibacterial activity against Klebsiella pneumoniae ATCC 700603,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
189581,,,6208985,[],CHEMBL1781755,Antibacterial activity against Pseudomonas aeruginosa 17,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
189582,,,6208986,[],CHEMBL1781756,Antibacterial activity against Shigella sonnei 51592,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,MIC,ug ml-1,UO_0000274,,0.03
189583,,,6208987,[],CHEMBL1781757,Antibacterial activity against Bacillus typhi 50035,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,0.03
189584,,,6208988,[],CHEMBL1781758,Antibacterial activity against Enterobacter cloacae 45301,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.03
189585,,,6208989,[],CHEMBL1781759,Antibacterial activity against Acinetobacter calcoaceticus 25001,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,0.125
189586,,,6208990,[],CHEMBL1781760,Antibacterial activity against Enterobacter aerogenes 45102,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.03
189587,,,6208991,[],CHEMBL1781761,Antibacterial activity against Serratia marcescens 41002,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.125
189588,,,6208992,[],CHEMBL1781762,Antibacterial activity against Morganella morganii 49086,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.06
189589,,,6208993,[],CHEMBL1781763,Antibacterial activity against Proteus rettgeri 49006,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.06
189590,,,6208994,[],CHEMBL1781764,Antibacterial activity against Proteus vulgaris 56,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1777766,Bioorg Med Chem Lett,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1424189,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.03
189591,,,6228613,[],CHEMBL1785786,Cytotoxicity against MDCK cells after 48 hrs by CPE assay,A,,,BAO_0000187,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,1427622,=,1,1,=,,CC50,nM,,321000.0,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,,CC50,uM,UO_0000065,,321.0
189592,,,6229756,[],CHEMBL1785609,Antibacterial activity against 10'4 CFU Staphylococcus aureus ATCC 25923 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
189593,,,6229757,[],CHEMBL1785610,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
189594,,,6229758,[],CHEMBL1785772,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
189595,,,6229759,[],CHEMBL1785773,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus epidermidis 09-6 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
189596,,,6229760,[],CHEMBL1785774,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus epidermidis 09-2 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
189597,,,6229761,[],CHEMBL1785775,Antibacterial activity against 10'4 CFU Streptococcus pneumoniae 08-4 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189598,,,6229762,[],CHEMBL1785776,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-10 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,16.0
189599,,,6229763,[],CHEMBL1785777,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-12 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,16.0
189600,,,6229764,[],CHEMBL1785778,Antibacterial activity against 10'4 CFU Enterococcus faecium 08-2 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
189601,,,6229765,[],CHEMBL1785779,Antibacterial activity against 10'4 CFU Enterococcus faecium 06-7 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,16.0
189602,,,6229766,[],CHEMBL1785780,Antibacterial activity against 10'4 CFU Escherichia coli ATCC 25922 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
189603,,,6229767,[],CHEMBL1785781,Antibacterial activity against 10'4 CFU Escherichia coli 08-21 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
189604,,,6229768,[],CHEMBL1785782,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-22 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
189605,,,6229769,[],CHEMBL1785783,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-23 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
189606,,,6229770,[],CHEMBL1785784,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa ATCC 27853 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
189607,,,6229771,[],CHEMBL1785785,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa 09-32 after 18 hrs by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1781961,Eur J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427622,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
189608,,,7829335,[],CHEMBL1909307,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_bilirubinemia,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_bilirubinemia,,,,1.0
189609,,,7829336,[],CHEMBL1909308,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_cholecystitis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholecystitis,,,,0.0
189610,,,7829337,[],CHEMBL1909309,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_cholelithiasis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholelithiasis,,,,0.0
189611,,,7829338,[],CHEMBL1909310,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_cirrhosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cirrhosis,,,,0.0
189612,,,7829339,[],CHEMBL1909311,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_elevated liver function tests,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_elevated liver function tests,,,,0.0
189613,,,7829340,[],CHEMBL1909312,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_hepatic failure,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic failure,,,,0.0
189614,,,7829341,[],CHEMBL1909313,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_hepatic necrosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic necrosis,,,,0.0
189615,,,7829342,[],CHEMBL1909314,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_hepatitis,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatitis,,,,1.0
189616,,,7829343,[],CHEMBL1909315,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_hepatomegaly,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatomegaly,,,,0.0
189617,,,7829344,[],CHEMBL1909316,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_jaundice,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_jaundice,,,,1.0
189618,,,7829345,[],CHEMBL1909317,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_liver disease,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver disease,,,,0.0
189619,,,7829346,[],CHEMBL1909318,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_liver fatty,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver fatty,,,,0.0
189620,,,7829347,[],CHEMBL1909319,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_liver function tests abnormal,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver function tests abnormal,,,,0.0
189621,,,7829348,[],CHEMBL1909320,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,A,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1540870,=,1,0,=,,HepSE_Combined Scores,,,3.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_Combined Scores,,,,3.0
189622,,,7975735,[],CHEMBL1929933,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
189623,,,7975736,[],CHEMBL1929934,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
189624,,,7975737,[],CHEMBL1929935,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
189625,,,7975738,[],CHEMBL1929936,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
189626,,,7975739,[],CHEMBL1929937,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-4 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
189627,,,7975740,[],CHEMBL1929938,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
189628,,,7975741,[],CHEMBL1931190,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
189629,,,7975742,[],CHEMBL1931191,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
189630,,,7975743,[],CHEMBL1931192,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-4 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.015
189631,,,7975744,[],CHEMBL1931193,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-5 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
189632,,,7975745,[],CHEMBL1931194,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-6 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
189633,,,7975746,[],CHEMBL1931195,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
189634,,,7975747,[],CHEMBL1931196,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
189635,,,7975748,[],CHEMBL1931197,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
189636,,,7975749,[],CHEMBL1931198,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,16.0
189637,,,7975750,[],CHEMBL1931199,Antibacterial activity against Streptococcus pneumoniae 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
189638,,,7975751,[],CHEMBL1931200,Antibacterial activity against Enterococcus faecium 09-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,16.0
189639,,,7975752,[],CHEMBL1931201,Antibacterial activity against Enterococcus faecium 09-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,4.0
189640,,,7975753,[],CHEMBL1931202,Antibacterial activity against Enterococcus faecium 09-4 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.03
189641,,,7975754,[],CHEMBL1931203,Antibacterial activity against Enterococcus faecium 09-5 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,16.0
189642,,,7975755,[],CHEMBL1931204,Antibacterial activity against Enterococcus faecium 09-6 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.03
189643,,,7975756,[],CHEMBL1931205,Antibacterial activity against Enterococcus faecalis 09-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.0
189644,,,7975757,[],CHEMBL1931206,Antibacterial activity against Enterococcus faecalis 09-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
189645,,,7975758,[],CHEMBL1931207,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
189646,,,7975759,[],CHEMBL1931208,Antibacterial activity against Escherichia coli 09-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
189647,,,7975760,[],CHEMBL1931209,Antibacterial activity against Escherichia coli 09-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
189648,,,7975761,[],CHEMBL1931287,Antibacterial activity against Escherichia coli 09-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
189649,,,7975762,[],CHEMBL1929633,Antibacterial activity against Escherichia coli 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
189650,,,7975763,[],CHEMBL1929634,Antibacterial activity against Escherichia coli 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
189651,,,7975764,[],CHEMBL1929635,Antibacterial activity against Escherichia coli 10-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
189652,,,7975765,[],CHEMBL1929636,Antibacterial activity against Klebsiella pneumoniae 09-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
189653,,,7975766,[],CHEMBL1929637,Antibacterial activity against Klebsiella pneumoniae 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.015
189654,,,7975767,[],CHEMBL1929638,Antibacterial activity against Klebsiella pneumoniae 10-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
189655,,,7975768,[],CHEMBL1929639,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
189656,,,7975769,[],CHEMBL1929640,Antibacterial activity against Pseudomonas aeruginosa 10-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
189657,,,7975770,[],CHEMBL1929641,Antibacterial activity against Pseudomonas aeruginosa 10-2 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
189658,,,7975771,[],CHEMBL1929642,Antibacterial activity against Pseudomonas aeruginosa 10-3 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
189659,,,7975818,[],CHEMBL1929689,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-2 infected KM mouse systemic infection model assessed as decrease in mouse mortality administered orally twice after 1 and 4 hrs post infection measured up to 7 days,F,,,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1563533,=,1,1,=,,ED50,mg.kg-1,,14.86,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,14.86
189660,,,7975822,[],CHEMBL1929690,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-4 infected KM mouse systemic infection model assessed as decrease in mouse mortality administered orally twice after 1 and 4 hrs post infection measured up to 7 days,F,,,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1563533,=,1,1,=,,ED50,mg.kg-1,,24.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,ED50,mg kg-1,UO_0000308,,24.0
189661,,,7975826,[],CHEMBL1929858,Antibacterial activity against Escherichia coli 10-2 infected KM mouse systemic infection model assessed as decrease in mouse mortality administered orally twice after 1 and 4 hrs post infection measured up to 7 days,F,,,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1563533,=,1,1,=,,ED50,mg.kg-1,,6.86,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,6.86
189662,,,7975830,[],CHEMBL1929859,Antibacterial activity against Klebsiella pneumoniae 10-3 infected KM mouse systemic infection model assessed as decrease in mouse mortality administered orally twice after 1 and 4 hrs post infection measured up to 7 days,F,,,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1563533,=,1,1,=,,ED50,mg.kg-1,,108.46,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,ED50,mg kg-1,UO_0000308,,108.46
189663,,,7975834,[],CHEMBL1929860,Antibacterial activity against Pseudomonas aeruginosa 10-1 infected KM mouse systemic infection model assessed as decrease in mouse mortality administered orally twice after 1 and 4 hrs post infection measured up to 7 days,F,,,BAO_0003036,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1563533,=,1,1,=,,ED50,mg.kg-1,,129.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,ED50,mg kg-1,UO_0000308,,129.4
189664,,,7977057,[],CHEMBL1929688,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-4 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,4.0
189665,,,7977062,[],CHEMBL1929863,Antibacterial activity against Enterococcus faecium 09-1 after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL1926550,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563533,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,16.0
189666,,,10974515,[],CHEMBL2065876,Antimicrobial activity against Staphylococcus aureus ATCC 259223 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
189667,,,10974540,[],CHEMBL2065877,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-resistant Staphylococcus aureus 10-11 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189668,,,10974565,[],CHEMBL2065878,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-resistant Staphylococcus aureus 10-15 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
189669,,,10974590,[],CHEMBL2065879,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-sensitive Staphylococcus aureus 10-13 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
189670,,,10974615,[],CHEMBL2065880,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-sensitive Staphylococcus aureus 10-14 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
189671,,,10974640,[],CHEMBL2065881,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-resistant Staphylococcus epidermidis 10-10 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
189672,,,10974665,[],CHEMBL2065882,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-resistant Staphylococcus epidermidis 10-13 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
189673,,,10974690,[],CHEMBL2065883,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-sensitive Staphylococcus epidermidis 10-11 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,16.0
189674,,,10974715,[],CHEMBL2065884,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-sensitive Staphylococcus epidermidis 10-13 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
189675,,,10975953,[],CHEMBL2065885,Antimicrobial activity against extended spectrum beta-lactamases-producing methicillin-sensitive Staphylococcus epidermidis 10-15 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,16.0
189676,,,10975978,[],CHEMBL2065886,Antimicrobial activity against Enterococcus faecalis 10-5 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
189677,,,10976003,[],CHEMBL2065887,Antimicrobial activity against Enterococcus faecalis 10-6 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
189678,,,10976028,[],CHEMBL2065888,Antimicrobial activity against Enterococcus faecalis 10-7 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.0
189679,,,10976053,[],CHEMBL2065889,Antimicrobial activity against Enterococcus faecium 10-5 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,8.0
189680,,,10976078,[],CHEMBL2065890,Antimicrobial activity against Enterococcus faecium 10-9 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,8.0
189681,,,10976103,[],CHEMBL2065891,Antimicrobial activity against extended spectrum beta-lactamases-producing Streptococcus pneumoniae 10-1 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
189682,,,10976128,[],CHEMBL2065892,Antimicrobial activity against extended spectrum beta-lactamases-producing Streptococcus pneumoniae 10-4 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
189683,,,10976153,[],CHEMBL2065893,Antimicrobial activity against Escherichia coli ATCC 25922 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
189684,,,10976178,[],CHEMBL2065894,Antimicrobial activity against Escherichia coli 10-1 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
189685,,,10976203,[],CHEMBL2065895,Antimicrobial activity against Escherichia coli 10-2 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
189686,,,10977460,[],CHEMBL2065896,Antimicrobial activity against extended spectrum beta-lactamases-producing Escherichia coli 10-2 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
189687,,,10977485,[],CHEMBL2065897,Antimicrobial activity against Escherichia coli 10-3 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
189688,,,10977510,[],CHEMBL2065898,Antimicrobial activity against extended spectrum beta-lactamases-producing Escherichia coli 10-3 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
189689,,,10977535,[],CHEMBL2065899,Antimicrobial activity against extended spectrum beta-lactamases-producing Escherichia coli 10-4 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
189690,,,10977560,[],CHEMBL2065900,Antimicrobial activity against extended spectrum beta-lactamases-producing Klebsiella pneumoniae 10-1 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
189691,,,10977585,[],CHEMBL2065901,Antimicrobial activity against Klebsiella pneumoniae 10-2 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
189692,,,10977610,[],CHEMBL2065902,Antimicrobial activity against extended spectrum beta-lactamases-producing Klebsiella pneumoniae 10-2 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
189693,,,10977635,[],CHEMBL2065903,Antimicrobial activity against Klebsiella pneumoniae 10-3 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
189694,,,10977660,[],CHEMBL2065904,Antimicrobial activity against extended spectrum beta-lactamases-producing Klebsiella pneumoniae 10-3 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
189695,,,10977685,[],CHEMBL2065905,Antimicrobial activity against Klebsiella pneumoniae 10-4 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
189696,,,10977710,[],CHEMBL2065906,Antimicrobial activity against Pseudomonas aeruginosa 10-12 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.03
189697,,,10977735,[],CHEMBL2065907,Antimicrobial activity against extended spectrum beta-lactamases-producing Pseudomonas aeruginosa 10-5 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
189698,,,10978998,[],CHEMBL2065908,Antimicrobial activity against extended spectrum beta-lactamases-producing Pseudomonas aeruginosa 10-9 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
189699,,,10979023,[],CHEMBL2066575,Antimicrobial activity against extended spectrum beta-lactamases-producing Pseudomonas aeruginosa 10-15 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
189700,,,10979048,[],CHEMBL2066576,Antimicrobial activity against extended spectrum beta-lactamases-producing Pseudomonas aeruginosa 10-18 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
189701,,,10979073,[],CHEMBL2066577,Antimicrobial activity against extended spectrum beta-lactamases-producing Pseudomonas aeruginosa 10-20 after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
189702,,,10979076,[],CHEMBL2066578,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,2.0
189703,,,10979079,[],CHEMBL2066578,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
189704,,,10979081,[],CHEMBL2066579,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolate after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,0.25
189705,,,10979083,[],CHEMBL2066579,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolate after 18-24 hrs by two-fold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2062435,Eur J Med Chem,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658368,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,8.0
189706,,Not Determined,12070074,[],CHEMBL2162878,Inhibition of human ERG expressed in mammalian cells at 10 uM by patch clamp method,B,,,BAO_0000201,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,1732871,,1,0,,,Inhibition,%,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,INH,,UO_0000187,,
189707,,Not Determined,12070085,[],CHEMBL2162877,Cytotoxicity against human HepG2 cell line after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1732871,,1,0,,,CC50,,,,CHEMBL395,Homo sapiens,HepG2,9606.0,,,CC50,,,,
189708,,Not Determined,12070096,[],CHEMBL2162876,Cytotoxicity against human HeLa cell line after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1732871,,1,0,,,CC50,,,,CHEMBL399,Homo sapiens,HeLa,9606.0,,,CC50,,,,
189709,,Not Determined,12070107,[],CHEMBL2162875,Cytotoxicity against human CHO cell line after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1732871,,1,0,,,CC50,,,,CHEMBL613853,Cricetulus griseus,CHO,10029.0,,,CC50,,,,
189710,,,12070118,[],CHEMBL2162874,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 5-FQR4M BSA678 expressing GyrA Ser84Leu and Ser85Pro mutant and GrlA Ser80Phe and Glu84Lys mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
189711,,,12070129,[],CHEMBL2162873,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 4-FQR3M BSA643 expressing GyrA Ser84Leu mutant and GrlA Ser80Tyr and Glu84Gly mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
189712,,,12070140,[],CHEMBL2162872,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 3-FQR3M ATCC 700699 expressing GyrA Ser84Leu mutant and Glu409Lys mutant and GrlA Ser80Phe mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189713,,,12070151,[],CHEMBL2162871,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 2-FQR2M NY2746 expressing GyrA Ser84Leu mutant and GrlA Ser80Phe mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
189714,,,12070162,[],CHEMBL2162870,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 1-FQR2M BK2384 expressing GyrA Ser84Leu mutant and GrlA Ser80Phe mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
189715,,,12070173,[],CHEMBL2161981,Cytotoxicity against human Hep2 cell line after 72 hrs,A,,,BAO_0000187,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,1732871,=,1,1,=,,CC50,nM,,46000.0,CHEMBL614735,Homo sapiens,HEp-2,9606.0,,,CC50,uM,UO_0000065,,46.0
189716,,,12070194,[],CHEMBL2161980,Inhibition of Staphylococcus aureus topoisomerase 4 by decatenation assay,B,,,BAO_0000190,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,6.4,0,http://www.openphacts.org/units/Nanomolar,1732871,=,1,1,=,,IC50,nM,,400.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.4
189717,,,12070215,[],CHEMBL2161979,Inhibition of Staphylococcus aureus DNA gyrase by supercoiling assay,B,,,BAO_0000190,BAO_0000223,protein complex format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,"{'bei': '13.49', 'le': '0.26', 'lle': '4.28', 'sei': '4.27'}",CHEMBL430,GEMIFLOXACIN,CHEMBL430,5.25,1,http://www.openphacts.org/units/Nanomolar,1732871,=,1,1,=,,IC50,nM,,5600.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,5.6
189718,,,12070236,[],CHEMBL2161978,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189719,,,12070257,[],CHEMBL2161977,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2157972,J Med Chem,2011.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732871,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
189720,,,12532087,[],CHEMBL3077735,Toxicity in healthy Homo sapiens (human),T,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3046014,Med Chem Res,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1825951,=,1,0,=,,MNTD,mg,,800.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,MNTD,mg,UO_0000022,,800.0
189721,,,12532088,[],CHEMBL3077734,Elimination half life in healthy Homo sapiens (human),A,,,BAO_0002115,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3046014,Med Chem Res,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,1825951,=,1,1,=,,T1/2,hr,,7.4,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,beta t1/2,hr,UO_0000032,,7.4
189722,,,12532089,[],CHEMBL3077736,Oral bioavailability in healthy Homo sapiens (human),A,,,BAO_0003042,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3046014,Med Chem Res,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,1825951,=,1,1,=,,F,%,,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F,%,UO_0000187,,70.0
189723,,,12532090,[],CHEMBL3077737,Antitubercular activity against Mycobacterium tuberculosis,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3046014,Med Chem Res,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825951,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,8.0
189724,,,12644245,[],CHEMBL2330399,Antibacterial activity against Chlamydophila pneumoniae CM-1 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853500,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL612694,Chlamydia pneumoniae,Chlamydia pneumoniae,83558.0,,,MIC,ug ml-1,UO_0000274,,0.063
189725,,,12644246,[],CHEMBL2330400,Antibacterial activity against Chlamydophila pneumoniae AR39 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853500,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612694,Chlamydia pneumoniae,Chlamydia pneumoniae,83558.0,,,MIC,ug ml-1,UO_0000274,,0.125
189726,,,12644247,[],CHEMBL2330401,Antibacterial activity against Mycoplasma pneumoniae ATCC 29085 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853500,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.25
189727,,,12644248,[],CHEMBL2330402,Antibacterial activity against Mycoplasma pneumoniae 18-1 after 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853500,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.25
189728,,,12676114,[],CHEMBL2344267,Antibacterial activity against Staphylococcus aureus ATCC 259233,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,<,1,1,<,,MIC,ug.mL-1,,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.008
189729,,,12676170,[],CHEMBL2346118,Antibacterial activity against Pseudomonas aeruginosa isolate 12-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
189730,,,12678617,[],CHEMBL2344247,Antibacterial activity against extended-spectrum beta-lactamase-producing Escherichia coli isolate 12-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
189731,,,12678619,[],CHEMBL2344249,Antibacterial activity against Escherichia coli isolate 12-5,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
189732,,,12678620,[],CHEMBL2344250,Antibacterial activity against Escherichia coli isolate 12-4,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
189733,,,12678634,[],CHEMBL2346119,Antibacterial activity against Pseudomonas aeruginosa isolate 12-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
189734,,,12678652,[],CHEMBL2344248,Antibacterial activity against extended-spectrum beta-lactamase-producing Escherichia coli isolate 12-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
189735,,,12678693,[],CHEMBL2344256,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate 12-33,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,4.0
189736,,,12678703,[],CHEMBL2344265,Antibacterial activity against methicillin-sensitive Staphylococcus aureus isolate 12-7,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189737,,,12678706,[],CHEMBL2346121,Antibacterial activity against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolate 12-4,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
189738,,,12678708,[],CHEMBL2346122,Antibacterial activity against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolate 12-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
189739,,,12678710,[],CHEMBL2346123,Antibacterial activity against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolate 12-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
189740,,,12678724,[],CHEMBL2344246,Antibacterial activity against extended-spectrum beta-lactamase-producing Escherichia coli isolate 12-4,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
189741,,,12678748,[],CHEMBL2346120,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
189742,,,12681509,[],CHEMBL2344253,Antibacterial activity against Streptococcus pneumoniae isolate 12-5,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189743,,,12681511,[],CHEMBL2344254,Antibacterial activity against Streptococcus pneumoniae isolate 12-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
189744,,,12681526,[],CHEMBL2344259,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis isolate 12-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
189745,,,12681565,[],CHEMBL2344251,Antibacterial activity against Escherichia coli isolate 12-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
189746,,,12681596,[],CHEMBL2346124,Antibacterial activity against Klebsiella pneumoniae isolate 12-4,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
189747,,,12681598,[],CHEMBL2346125,Antibacterial activity against Klebsiella pneumoniae isolate 12-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
189748,,,12681608,[],CHEMBL2344258,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis isolate 12-3,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
189749,,,12681610,[],CHEMBL2344260,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis isolate 12-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
189750,,,12681621,[],CHEMBL2346126,Antibacterial activity against Klebsiella pneumoniae isolate 12-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.03
189751,,,12681623,[],CHEMBL2344261,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 12-15,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
189752,,,12681626,[],CHEMBL2344263,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 12-3,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
189753,,,12681628,[],CHEMBL2344264,Antibacterial activity against methicillin-sensitive Staphylococcus aureus isolate 12-10,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
189754,,,12681631,[],CHEMBL2344266,Antibacterial activity against methicillin-sensitive Staphylococcus aureus isolate 12-6,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
189755,,,12681635,[],CHEMBL2344252,Antibacterial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
189756,,,12681642,[],CHEMBL2344257,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate 12-5,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.015
189757,,,12681645,[],CHEMBL2344262,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 12-13,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.015
189758,,,12681647,[],CHEMBL2344255,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate 12-35,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL2331542,Bioorg Med Chem Lett,2013.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871293,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.008
189759,,references out of a total of 4,13980615,[],CHEMBL3137722,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,=,1,0,=,,Hepatotoxicity (moderate),,,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (moderate),,,,4.0
189760,,,13980616,[],CHEMBL3137723,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,1979621,=,1,0,=,,Hepatotoxicity (moderate),%,,0.3,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (moderate),%,UO_0000187,,0.3
189761,,references out of a total of 4,13980617,[],CHEMBL3137724,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,=,1,0,=,,Hepatotoxicity (acute),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (acute),,,,0.0
189762,,,13980618,[],CHEMBL3137725,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,1979621,=,1,0,=,,Hepatotoxicity (acute),%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (acute),%,UO_0000187,,0.0
189763,,references out of a total of 4,13980619,[],CHEMBL3137726,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,=,1,0,=,,Hepatotoxicity (cytolytic),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (cytolytic),,,,0.0
189764,,references out of a total of 4,13980620,[],CHEMBL3137727,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,=,1,0,=,,Hepatotoxicity (choleostasis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (choleostasis),,,,0.0
189765,,references out of a total of 4,13980621,[],CHEMBL3137728,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,=,1,0,=,,Hepatotoxicity (severe hepatitis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (severe hepatitis),,,,0.0
189766,,references out of a total of 4,13980622,[],CHEMBL3137729,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,=,1,0,=,,Hepatotoxicity (chronic liver disease),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (chronic liver disease),,,,0.0
189767,,references out of a total of 4,13980623,[],CHEMBL3137730,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,=,1,0,=,,Hepatotoxicity (cirrhosis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (cirrhosis),,,,0.0
189768,,references out of a total of 4,13980624,[],CHEMBL3137731,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,=,1,0,=,,Hepatotoxicity (granulomatous hepatitis),,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (granulomatous hepatitis),,,,0.0
189769,,references out of a total of 4,13980625,[],CHEMBL3137732,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,=,1,0,=,,Hepatotoxicity (association with vascular disease),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (association with vascular disease),,,,0.0
189770,,references out of a total of 4,13980626,[],CHEMBL3137733,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,=,1,0,=,,Hepatotoxicity (steatosis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (steatosis),,,,0.0
189771,,references out of a total of 4,13980627,[],CHEMBL3137734,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,=,1,0,=,,Hepatotoxicity (malignant tumour),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (malignant tumour),,,,0.0
189772,,references out of a total of 4,13980628,[],CHEMBL3137735,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,=,1,0,=,,Hepatotoxicity (benign tumour),,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (benign tumour),,,,0.0
189773,,,13980629,[],CHEMBL3137736,Animal toxicity known. [column 'TOXIC' in source],T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,,1,0,,,Hepatotoxicity (animal toxicity known),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (animal toxicity known),,,,
189774,,,13980630,[],CHEMBL3137737,Presence of at least one case with successful reintroduction. [column 'REINT' in source],T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,,1,0,,,Hepatotoxicity (successful reintroduction),,,,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (successful reintroduction),,,,
189775,,,13980631,[],CHEMBL3137738,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,,1,0,,,Hepatotoxicity (comment),,,,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (comment),,,,
189776,,6 days,13980632,[],CHEMBL3137739,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,,1,0,,,Hepatotoxicity (time to onset),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (time to onset),,,,
189777,,,13980633,[],CHEMBL3137740,Proposed mechanism(s) of liver damage. [column 'MEC' in source],T,,,BAO_0000179,BAO_0000221,tissue-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,1979621,,1,0,,,Hepatotoxicity (mechanism),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (mechanism),,,,
189778,,"""A1 Functional Group: Carboxylic acid; Ionisation Formula: A1B1 (Functional Group: the part of the molecule the pKa refers to; Ionisation formula: AxBy where 'A' refers to acidic centers within the molecule that are appreciably ionised at a pH <= 11 and 'x' equals 0, 1 or 2; and 'B' refers to basic centers within the molecule that are appreciably ionised at a pH >= 2 and 'y' equals 0, 1, 2 or 3).""",14759379,[],CHEMBL3301375,ASTRAZENECA: Most acidic pKa value (pKa A1) determined by absorption and potentiometric titration using standard methodology from Sirius Analytical. Experimental range Acids: <= 11.,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3301361,,,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,2129573,,27,0,,,pKa_A1,,,6.36,CHEMBL2362975,,No relevant target,,,,pKa_A1,,,,6.36
189779,,"""B1 Functional Group: Primary amine; Ionisation Formula: A1B1 (Functional Group: the part of the molecule the pKa refers to; Ionisation formula: AxBy where 'A' refers to acidic centers within the molecule that are appreciably ionised at a pH <= 11 and 'x' equals 0, 1 or 2; and 'B' refers to basic centers within the molecule that are appreciably ionised at a pH >= 2 and 'y' equals 0, 1, 2 or 3).""",14767683,[],CHEMBL3301362,ASTRAZENECA: Most basic pKa value (pKa B1) determined by absorption and potentiometric titration using standard methodology from Sirius Analytical. Experimental range Bases: >= 2.,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL3301361,,,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,2129573,,27,0,,,pKa_B1,,,8.6,CHEMBL2362975,,No relevant target,,,,pKa_B1,,,,8.6
189780,,,18080690,[],CHEMBL4017550,Inhibition of human BSEP expressed in baculovirus transfected fall armyworm Sf21 cell membranes vesicles assessed as reduction in ATP-dependent [3H]-taurocholate transport into vesicles incubated for 5 mins by Topcount based rapid filtration method,A,,,BAO_0000190,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4017441,Drug Metab Dispos,2012.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,2997430,>,1,1,>,,IC50,nM,,1000000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,IC50,uM,UO_0000065,,1000.0
189781,,,18132185,[],CHEMBL4029349,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index,T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,3007183,=,1,0,=,,DILI_severity_class,,,3.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_severity_class,,,,3.0
189782,,Less-Dili-Concern,18132785,[],CHEMBL4029350,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status,T,,,BAO_0000179,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,3007183,,1,0,,,DILI_Concern,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_Concern,,,,
189783,,,18835300,[],CHEMBL4303810,Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits),F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4303122,,2020.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,3141570,=,52,0,=,,Hit score,,,0.07253,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Hit score,,,,0.072534442
189784,,,19051585,[],CHEMBL4354972,Antibacterial activity against Pseudomonas aeruginosa by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,mg/L,UO_0000274,,4.0
189785,,,19051599,[],CHEMBL4354971,Antibacterial activity against Escherichia coli by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,0.03
189786,,,19051611,[],CHEMBL4354973,Antibacterial activity against Klebsiella by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC90,mg/L,UO_0000274,,0.25
189787,,Not Determined,19051625,[],CHEMBL4354974,Antibacterial activity against Bacteroides fragilis by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,3178406,,1,0,,,MIC90,,,,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,,,,
189788,,,19051639,[],CHEMBL4354975,Antibacterial activity against Haemophilus influenzae with horse blood by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,mg/L,UO_0000274,,0.06
189789,,,19051653,[],CHEMBL4354976,Antibacterial activity against Staphylococcus aureus by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,0.06
189790,,,19051667,[],CHEMBL4354977,Antibacterial activity against Streptococcus pneumoniae by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,mg/L,UO_0000274,,0.03
189791,,,19051681,[],CHEMBL4354978,Antibacterial activity against Streptococcus pyogenes by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,mg/L,UO_0000274,,0.06
189792,,,19051695,[],CHEMBL4354979,Antibacterial activity against Enterococcus by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178406,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC90,mg/L,UO_0000274,,4.0
189793,,Not Determined,19051709,[],CHEMBL4354980,Antibacterial activity against Clostridium perfringens by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,3178406,,1,0,,,MIC90,,,,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC90,,,,
189794,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,19051764,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'g', 'standard_value': '0.32', 'text_value': None, 'type': 'DOSE', 'units': 'g', 'value': '0.32'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL4355007,"Cmax in human at 0.32 g, po",A,,,BAO_0002119,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3178406,=,1,1,=,,Cmax,nM,,2568.12,CHEMBL612558,,ADMET,,,,Cmax,mg/L,UO_0000065,,1.0
189795,,,19051765,[],CHEMBL4355008,"AUC in human at 0.32 g, po",A,,,BAO_0002120,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,,3178406,=,1,1,=,,AUC,ng.hr.mL-1,,9000.0,CHEMBL612558,,ADMET,,,,AUC,mg.hr/L,,,9.0
189796,,,19051766,[],CHEMBL4355009,"Half life in human at 0.32 g, po",A,,,BAO_0002115,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Hour,3178406,=,1,1,=,,T1/2,hr,,7.0,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,7.0
189797,,,19051767,[],CHEMBL4355010,"Protein binding in human at 0.32 g, po",A,,,BAO_0000179,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,3178406,=,1,1,=,,PPB,%,,60.0,CHEMBL612558,,ADMET,,,,PB,%,UO_0000187,,60.0
189798,,,19957097,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4495564,,2020.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,3343515,=,52,1,=,,Inhibition,%,,16.45,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,16.45
189799,,,20150102,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4495565,,2020.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,3361387,=,52,1,=,,Inhibition,%,,0.09,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,0.09
189800,,,22072877,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4495565,,2020.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,3361387,=,52,1,=,,Inhibition,%,,0.09,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,0.09
189801,,,22895259,[],CHEMBL4730313,Genotoxicity in mouse L5178Y cells using DAPI staining by microscopy based micronucleation assay,T,,,BAO_0000179,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4725408,J Med Chem,2020.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Micromolar,3553692,=,1,0,=,,NOAEL,uM,,3.0,CHEMBL614720,Mus musculus,L5178Y,10090.0,,,NOAEL,uM,UO_0000064,,3.0
189802,,,23131924,[],CHEMBL4808149,Enzymatic assay of human HDAC6 with commercial peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4808148,,2021.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,3591602,=,59,1,=,,Inhibition,%,,-3.85,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,-3.85
189803,,,23135731,[],CHEMBL4808150,Enzymatic assay of human HDAC6 with custom peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL4808148,,2021.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://qudt.org/vocab/unit#Percent,3591602,=,59,1,=,,Inhibition,%,,-6.79,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,-6.79
189804,,,24837165,[],CHEMBL5144782,Antibacterial activity against rifampicin resistant Staphylococcus aureus harboring RpoBH481Y mutant assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879314,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.016
189805,,,24837200,[],CHEMBL5144783,Antibacterial activity against wild type Staphylococcus aureus assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879314,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.016
189806,,,24837235,[],CHEMBL5144784,Antibacterial activity against ciprofloxacin resistant Staphylococcus aureus harboring ParCS80F and GyrAS84L double mutant assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879314,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
189807,,,24837270,[],CHEMBL5144785,Antibacterial activity against Staphylococcus aureus harboring RpoBH481Y/ParCS80F/GyrAS84L triple mutant assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879314,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
189808,,,24837305,[],CHEMBL5144786,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879314,=,1,1,=,,MIC,ug.mL-1,,0.0078,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0078
189809,,,25040727,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5244791,Antimicrobial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs by Alamar blue staining based analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922853,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
189810,,,25040749,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5244793,Antimicrobial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs by Agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922853,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
189811,,,25041327,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5244894,Antibacterial activity against clinical isolate Escherichia coli assessed as bacterial growth inhibition incubated for 24 hrs by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3923178,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,32.0
189812,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25050568,[],CHEMBL5247172,Inhibition of DPP-4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5244277,Bioorg Med Chem,2021.0,"{'bei': '14.30', 'le': '0.27', 'lle': '4.60', 'sei': '4.53'}",CHEMBL430,GEMIFLOXACIN,CHEMBL430,5.57,0,http://www.openphacts.org/units/Nanomolar,3926323,=,1,1,=,,IC50,nM,,2700.0,CHEMBL284,Homo sapiens,Dipeptidyl peptidase IV,9606.0,,,IC50,uM,UO_0000065,,2.7
189813,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25115210,[],CHEMBL5291779,Binding affinity towards human DRD1 in an in vitro assay with cellular components (NIBR assay) measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,"{'bei': '11.65', 'le': '0.22', 'lle': '3.57', 'sei': '3.69'}",CHEMBL430,GEMIFLOXACIN,CHEMBL430,4.54,0,http://www.openphacts.org/units/Nanomolar,3940429,=,1,1,=,,AC50,nM,,29060.3,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,29.0603
189814,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25117618,[],CHEMBL5291828,"Compound was evaluated for inhibition of human KCNH2 in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,AC50,uM,UO_0000065,,30.0
189815,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25124959,[],CHEMBL5291882,Binding affinity towards human SLC6A3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
189816,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25138858,[],CHEMBL5291792,Binding affinity towards human ESR1 in an in vitro cell free assay (CRO assay) measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,AC50,uM,UO_0000065,,30.0
189817,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25142548,[],CHEMBL5291723,Compound was evaluated for inhibition of human ACHE in an vitro cell free assay measured by absorbance method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,AC50,uM,UO_0000065,,30.0
189818,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25146000,[],CHEMBL5291881,Binding affinity towards human SLC6A2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
189819,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25151327,[],CHEMBL5291883,Binding affinity towards human SLC6A4 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
189820,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25156429,[],CHEMBL5291736,Binding affinity towards human ADRA2A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189821,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25158175,[],CHEMBL5291855,Binding affinity towards human OPRM1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189822,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25160691,[],CHEMBL5291830,Compound was evaluated for inhibition of human MAOA in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,AC50,uM,UO_0000065,,30.0
189823,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25165024,[],CHEMBL5291815,Binding affinity towards human HTR1A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189824,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25168229,[],CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL279,Homo sapiens,Vascular endothelial growth factor receptor 2,9606.0,,,AC50,uM,UO_0000065,,30.0
189825,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25191717,[],CHEMBL5291856,Compound was evaluated for inhibition of human PDE3A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL241,Homo sapiens,Phosphodiesterase 3A,9606.0,,,AC50,uM,UO_0000065,,30.0
189826,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25194523,[],CHEMBL5291782,Binding affinity towards human DRD3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189827,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25195736,[],CHEMBL5291766,Binding affinity towards human CHRM2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,"{'bei': '12.23', 'le': '0.23', 'lle': '3.79', 'sei': '3.87'}",CHEMBL430,GEMIFLOXACIN,CHEMBL430,4.76,0,http://www.openphacts.org/units/Nanomolar,3940429,=,1,1,=,,AC50,nM,,17223.4,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,17.2234
189828,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25196706,[],CHEMBL5291794,Compound was evaluated for inhibition of human F2 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL204,Homo sapiens,Thrombin,9606.0,,,AC50,uM,UO_0000065,,30.0
189829,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25197858,[],CHEMBL5291888,Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189830,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25198717,[],CHEMBL5291728,Binding affinity towards human ADORA3 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189831,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25199532,[],CHEMBL5291812,Binding affinity towards human HRH3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL264,Homo sapiens,Histamine H3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189832,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25201465,[],CHEMBL5291820,Agonist activity at human HTR2B in an in vitro cell-based assay (CRO assay) measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189833,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25202456,[],CHEMBL5291725,Binding affinity towards human ADORA1 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189834,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25203358,[],CHEMBL5291749,Binding affinity towards human AR in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1871,Homo sapiens,Androgen Receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189835,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25204291,[],CHEMBL5291863,Binding affinity towards human PGR in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189836,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25205224,[],CHEMBL5291869,Compound was evaluated for inhibition of human PTGS1 in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,AC50,uM,UO_0000065,,30.0
189837,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25206157,[],CHEMBL5291871,Compound was evaluated for inhibition of human PTGS1 in an in vitro cell free assay measured by fluorescence method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,AC50,uM,UO_0000065,,30.0
189838,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25207087,[],CHEMBL5291857,Compound was evaluated for inhibition of human PDE4A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL254,Homo sapiens,Phosphodiesterase 4A,9606.0,,,AC50,uM,UO_0000065,,30.0
189839,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25207886,[],CHEMBL5291800,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,30.0
189840,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25208528,[],CHEMBL5291730,Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189841,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25209375,[],CHEMBL5291759,Agonist activity at human CHRM1 in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
189842,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25210212,[],CHEMBL5291761,Antagonist activity human CHRM1 in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
189843,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25211094,[],CHEMBL5291887,Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189844,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25218849,[],CHEMBL5291731,Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189845,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25234655,[],CHEMBL5291733,Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
189846,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25234760,[],CHEMBL5291780,Binding affinity towards human DRD1 in an in vitro assay (CRO assay) measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,"{'bei': '13.98', 'le': '0.27', 'lle': '4.47', 'sei': '4.42'}",CHEMBL430,GEMIFLOXACIN,CHEMBL430,5.44,0,http://www.openphacts.org/units/Nanomolar,3940429,=,1,1,=,,AC50,nM,,3600.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,3.6
189847,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25234865,[],CHEMBL5291762,Binding affinity towards human CHRM1 in an in vitro assay measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL430,GEMIFLOXACIN,CHEMBL430,,0,http://www.openphacts.org/units/Nanomolar,3940429,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
189848,,,43133,[],CHEMBL760396,Minimum inhibitory concentration against Pasteurella multocida,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1134903,Bioorg Med Chem Lett,2002.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144360,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC,ug ml-1,UO_0000274,,0.1
189849,,,43134,[],CHEMBL682927,Minimum inhibitory concentration against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1134903,Bioorg Med Chem Lett,2002.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144360,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.56
189850,,,43135,[],CHEMBL814224,Minimum inhibitory concentration against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1134903,Bioorg Med Chem Lett,2002.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,144360,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
189851,,,43136,[],CHEMBL813000,Effective dose required to inhibit Staphylococcus aureus intraperitoneal (IP) infection model,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1134903,Bioorg Med Chem Lett,2002.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,144360,=,1,1,=,,ED50,mg.kg-1,,4.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,4.1
189852,,,43137,[],CHEMBL810861,Colony forming units of Staphylococcus aureus intramammary infection (IMI) model was determined at a dose of 15 mg/kg,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1134903,Bioorg Med Chem Lett,2002.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,144360,=,1,0,=,,Log CFU,,,2.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Log CFU,,,,2.8
189853,,,43138,[],CHEMBL639158,Calculated partition coefficient (clogP),P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1134903,Bioorg Med Chem Lett,2002.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,144360,=,1,1,=,,CLogP,,,1.826,CHEMBL2362975,,No relevant target,,,,clogP,,,,1.826
189854,,,66318,[],CHEMBL795180,Minimum inhibitory concentration against Staphylococcus aureus 10649 (erythromycin susceptible strain),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1134286,J Med Chem,2001.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,255107,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
189855,,,66319,[],CHEMBL736000,Mouse protection tests for effective dose against Staphylococcus aureus 10649 ((erythromycin susceptible strain)) infected mice,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1134286,J Med Chem,2001.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,255107,=,1,1,=,,ED50,mg.kg-1,,24.8,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,24.8
189856,,,66320,[],CHEMBL812546,Minimum inhibitory concentration against Streptococcus pneumoniae 6303 (erythromycin susceptible strain),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1134286,J Med Chem,2001.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,255107,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
189857,,,66321,[],CHEMBL740393,Effective dose against Streptococcus pneumoniae 6303 (erythromycin susceptible strain),F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1134286,J Med Chem,2001.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,255107,=,1,1,=,,ED50,mg.kg-1,,18.8,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,18.8
189858,,,66322,[],CHEMBL809733,Cell free inhibiting activity against Streptococcus pneumoniae 5635(Wild type ribosomes for transcription/translation assay),F,,,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1134286,J Med Chem,2001.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,6.77,0,http://www.openphacts.org/units/Nanomolar,255107,=,1,1,=,,IC50,nM,,170.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,IC50,uM,UO_0000065,,0.17
189859,,,66323,[],CHEMBL809732,Cell free inhibiting activity against Streptococcus pneumoniae 1813 (methylated ribosomes for transcription/translation assay),F,,,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1134286,J Med Chem,2001.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/Nanomolar,255107,>,1,1,>,,IC50,nM,,500000.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,IC50,uM,UO_0000065,,500.0
189860,,,243639,[],CHEMBL859379,Minimum inhibitory concentration required for antibacterial activity against Enterococcus faecalis MB 5407 strain;value ranges from 4-8,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
189861,,,243640,[],CHEMBL856960,Minimum inhibitory concentration required for antibacterial activity against Staphylococcus aureus MB 2865 strain;value ranges from 0.5-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
189862,,,243641,[],CHEMBL807176,Minimum inhibitory concentration required for antibacterial activity against Staphylococcus epidermidis MB 5414 strain;value ranges from 0.25-0.5,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
189863,,,243642,[],CHEMBL812378,Minimum inhibitory concentration required for antibacterial activity against Streptococcus pneumoniae CL 2883 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
189864,,,243643,[],CHEMBL809199,Minimum inhibitory concentration required for antibacterial activity against Streptococcus pyogenes MB 2874 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.06
189865,,,243644,[],CHEMBL677361,Minimum inhibitory concentration required for antibacterial activity against Enterobacter cloacae CL 4298 strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,1.0
189866,,,243645,[],CHEMBL678938,Minimum inhibitory concentration required for antibacterial activity against Escherichia coli MB 2884 strain;value ranges from 1-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
189867,,,243646,[],CHEMBL695874,Minimum inhibitory concentration required for antibacterial activity against Haemophilus influenzae MB 5363 strain;value ranges from 0.5-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
189868,,,243647,[],CHEMBL695869,Minimum inhibitory concentration required for antibacterial activity against Haemophilus influenzae CL 1830 strain;value ranges from 8-16,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,8.0
189869,,,243648,[],CHEMBL873319,Minimum inhibitory concentration required for antibacterial activity against Klebsiella pneumoniae MB 4005 strain;value ranges from 1-2,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1126507,Bioorg Med Chem Lett,1993.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,33476,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
189870,,,246631,[],CHEMBL810381,The compound has been evaluated for the antibacterial activity against Staphylococcus aureus EryS 011UC4 strains,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3
189871,,,246632,[],CHEMBL810380,The compound has been evaluated for the antibacterial activity against Staphylococcus aureus EryRi 011GO25i strains,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,40.0
189872,,,246633,[],CHEMBL811530,The compound has been evaluated for the antibacterial activity against Staphylococcus aureus EryRc 011CB20 strains,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,40.0
189873,,,246634,[],CHEMBL809706,The compound has been evaluated for the antibacterial activity against Streptococcus pyogenes EryS 02A1UC1.,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,=,1,1,=,,MIC,ug.mL-1,,0.6,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.6
189874,,,246635,[],CHEMBL811337,The compound has been evaluated for the antibacterial activity against Streptococcus pneumoniae EryS 032UC1 strains,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.15
189875,,,246636,[],CHEMBL814206,The compound has been evaluated for the antibacterial activity against Streptococcus pneumoniae EryRc 030PW23c strains,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,40.0
189876,,,246637,[],CHEMBL814207,The compound has been evaluated for the antibacterial activity against Streptococcus pneumoniae EryRc 030SJ1 strains,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,40.0
189877,,,246638,[],CHEMBL814205,The compound has been evaluated for the antibacterial activity against Streptococcus pneumoniae Ery Ri 030SJ 5i strains,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,40.0
189878,,,246639,[],CHEMBL689728,The compound has been evaluated for the antibacterial activity against Haemophilus influenzae 351HT3 (beta-lactamase +),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,107117,=,1,1,=,,MIC,ug.mL-1,,1.2,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,1.2
189879,,,246640,[],CHEMBL822738,The compound has been evaluated for the in vivo efficacy that protect 50% of mice from lethal infection of Staphylococcus aureus EryS 011HT17 strains after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,107117,=,1,1,=,,ED50,mg.kg-1,,72.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,72.0
189880,,,246641,[],CHEMBL883143,The compound has been evaluated for the in vivo efficacy that protect 50% of mice from lethal infection of Streptococcus Pneumonia EryS 032UC1 strain after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,107117,=,1,1,=,,ED50,mg.kg-1,,4.5,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,4.5
189881,,,246642,[],CHEMBL822739,The compound has been evaluated for the in vivo efficacy that protect 50% of mice from lethal infection of Streptococcus Pneumoniae EryRc 030MV2 strains after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,107117,>,1,1,>,,ED50,mg.kg-1,,50.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,50.0
189882,,,246643,[],CHEMBL822740,The compound has been evaluated for the in vivo efficacy that protect 50% of mice from lethal infection of Streptococcus Pneumoniae EryRi 030SJ5i strains after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,107117,>,1,1,>,,ED50,mg.kg-1,,50.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,50.0
189883,,,246644,[],CHEMBL822742,The compound has been evaluated for the in vivo efficacy that protect 50%of mice from lethal infection of Haemophilus influenzae AmpR 351RD7 after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1133301,Bioorg Med Chem Lett,2000.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,107117,=,1,1,=,,ED50,mg.kg-1,,94.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,94.0
189884,,,447151,[],CHEMBL807891,In vitro inhibitory activity against Staphylococcus aureus (011UC4),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3
189885,,,447152,[],CHEMBL810579,In vitro inhibitory activity against Staphylococcus aureus (EryRi 011GO25i),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,40.0
189886,,,447153,[],CHEMBL805299,In vitro inhibitory activity against Staphylococcus epidermidis (EryRi 012GO11i),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,40.0
189887,,,447154,[],CHEMBL883637,In vitro inhibitory activity against Staphylococcus aureus (EryRc 011CB20),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,40.0
189888,,,447155,[],CHEMBL812248,In vitro inhibitory activity against Streptococcus pneumoniae (EryRc 030SJ1),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,40.0
189889,,,447156,[],CHEMBL812249,In vitro inhibitory activity against Streptococcus pneumoniae (EryRi 030SJ5i),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,40.0
189890,,,447157,[],CHEMBL812247,In vitro inhibitory activity against Streptococcus pneumoniae (032UC1),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.15
189891,,,447158,[],CHEMBL813823,In vitro inhibitory activity against Streptococcus pyogenes (02A1UC1),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC,ug.mL-1,,0.6,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.6
189892,,,447159,[],CHEMBL690185,In vitro inhibitory activity against Haemophilus influenzae (351HT3),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC,ug.mL-1,,1.2,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,1.2
189893,,,447160,[],CHEMBL690184,In vitro inhibitory activity against Haemophilus influenzae (351CB12),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC,ug.mL-1,,1.2,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,1.2
189894,,,447161,[],CHEMBL683029,In vitro inhibitory activity against Escherichia coli (250 UC5),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,20.0
189895,,,447162,[],CHEMBL807026,In vitro inhibitory activity against Staphylococci EryRi (65),F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,,1,1,,,MIC50,ug.mL-1,,40.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC50,ug ml-1,UO_0000274,,40.0
189896,,,447163,[],CHEMBL809795,In vitro inhibitory activity against Staphylococci EryRi (65),F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC90,ug.mL-1,,40.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC90,ug ml-1,UO_0000274,,40.0
189897,,Not Determined,447164,[],CHEMBL807025,In vitro inhibitory activity against Staphylococci EryRc (23);ND=not determined,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,,1,0,,,MIC50,ug.mL-1,,,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC50,ug ml-1,UO_0000274,,
189898,,Not Determined,447165,[],CHEMBL809794,In vitro inhibitory activity against Staphylococci EryRc (23);ND=not determined,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,,1,0,,,MIC90,ug.mL-1,,,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC90,ug ml-1,UO_0000274,,
189899,,,447166,[],CHEMBL678986,In vitro inhibitory activity against enterococci EryRi (19),F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC50,ug.mL-1,,40.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC50,ug ml-1,UO_0000274,,40.0
189900,,,447167,[],CHEMBL678460,In vitro inhibitory activity against enterococci EryRi (19),F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC90,ug.mL-1,,40.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC90,ug ml-1,UO_0000274,,40.0
189901,,,447168,[],CHEMBL678983,In vitro inhibitory activity against enterococci EryRc (13),F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC50,ug.mL-1,,10.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC50,ug ml-1,UO_0000274,,10.0
189902,,,447169,[],CHEMBL679162,In vitro inhibitory activity against enterococci EryRc (13),F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC90,ug.mL-1,,40.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC90,ug ml-1,UO_0000274,,40.0
189903,,,447170,[],CHEMBL805504,In vitro inhibitory activity against Streptococci EryR (27),F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC50,ug.mL-1,,10.0,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC50,ug ml-1,UO_0000274,,10.0
189904,,,447171,[],CHEMBL806145,In vitro inhibitory activity against Streptococci EryR (27),F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC90,ug.mL-1,,40.0,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC90,ug ml-1,UO_0000274,,40.0
189905,,,447172,[],CHEMBL805507,In vitro inhibitory activity against Streptococci EryRi (98),F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC50,ug.mL-1,,40.0,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC50,ug ml-1,UO_0000274,,40.0
189906,,,447173,[],CHEMBL805375,In vitro inhibitory activity against Streptococci EryRi (98),F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC90,ug.mL-1,,40.0,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC90,ug ml-1,UO_0000274,,40.0
189907,,,447174,[],CHEMBL766974,In vitro inhibitory activity against Pneumococci EryRc (34),F,,,BAO_0003035,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC50,ug.mL-1,,40.0,CHEMBL612545,,Unchecked,,,,MIC50,ug ml-1,UO_0000274,,40.0
189908,,,447175,[],CHEMBL877859,In vitro inhibitory activity against Pneumococci EryRc (34),F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC90,ug.mL-1,,40.0,CHEMBL612545,,Unchecked,,,,MIC90,ug ml-1,UO_0000274,,40.0
189909,,,447176,[],CHEMBL766976,In vitro inhibitory activity against Pneumococci PenR (65),F,,,BAO_0003035,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC50,ug.mL-1,,2.5,CHEMBL612545,,Unchecked,,,,MIC50,ug ml-1,UO_0000274,,2.5
189910,,,447177,[],CHEMBL766982,In vitro inhibitory activity against Pneumococci PenR (65),F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC90,ug.mL-1,,40.0,CHEMBL612545,,Unchecked,,,,MIC90,ug ml-1,UO_0000274,,40.0
189911,,,447178,[],CHEMBL695046,In vitro inhibitory activity against Haemophilus AmpS (43),F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC50,ug.mL-1,,0.15,CHEMBL614407,Haemophilus,Haemophilus,724.0,,,MIC50,ug ml-1,UO_0000274,,0.15
189912,,,447179,[],CHEMBL689956,In vitro inhibitory activity against Haemophilus AmpS (43),F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC90,ug.mL-1,,1.2,CHEMBL614407,Haemophilus,Haemophilus,724.0,,,MIC90,ug ml-1,UO_0000274,,1.2
189913,,,447180,[],CHEMBL695045,In vitro inhibitory activity against Haemophilus AmpR (37),F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC50,ug.mL-1,,0.3,CHEMBL614407,Haemophilus,Haemophilus,724.0,,,MIC50,ug ml-1,UO_0000274,,0.3
189914,,,447181,[],CHEMBL692891,In vitro inhibitory activity against Haemophilus AmpR (37),F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,252675,=,1,1,=,,MIC90,ug.mL-1,,1.2,CHEMBL614407,Haemophilus,Haemophilus,724.0,,,MIC90,ug ml-1,UO_0000274,,1.2
189915,,,447182,[],CHEMBL813002,In Vivo evaluation for its effective dose against Staphylococcus aureus (011UC4). ,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,252675,=,1,1,=,,ED50,mg.kg-1,,60.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,60.0
189916,,,447183,[],CHEMBL813001,In Vivo evaluation for its effective dose against Staphylococcus aureus (011GO25 EryRi.,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,252675,>,1,1,>,,ED50,mg.kg-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,100.0
189917,,,447184,[],CHEMBL809716,In Vivo evaluation for its effective dose against Streptococcus pneumoniae (032UC1),F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,252675,>,1,1,>,,ED50,mg.kg-1,,50.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,ED50,mg kg-1,UO_0000308,,50.0
189918,,,447185,[],CHEMBL809657,In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030RO1 EryRi),F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,252675,>,1,1,>,,ED50,mg.kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,ED50,mg kg-1,UO_0000308,,100.0
189919,,,447186,[],CHEMBL809659,In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030SJ6 EryRc),F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,252675,>,1,1,>,,ED50,mg.kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,ED50,mg kg-1,UO_0000308,,100.0
189920,,,447187,[],CHEMBL809656,In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030MV2 EryRc),F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,252675,>,1,1,>,,ED50,mg.kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,ED50,mg kg-1,UO_0000308,,100.0
189921,,,447188,[],CHEMBL809658,In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030SJ1 EryRc),F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,252675,>,1,1,>,,ED50,mg.kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,ED50,mg kg-1,UO_0000308,,100.0
189922,,,447189,[],CHEMBL809655,In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030Cr29 EryRc),F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,252675,>,1,1,>,,ED50,mg.kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,ED50,mg kg-1,UO_0000308,,100.0
189923,,,447190,[],CHEMBL808174,In Vivo evaluation for its effective dose against Streptococcus pyogenes (02A1UC1),F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,252675,=,1,1,=,,ED50,mg.kg-1,,16.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,ED50,mg kg-1,UO_0000308,,16.0
189924,,,447191,[],CHEMBL694440,In Vivo evaluation for its effective dose against Haemophilus influenzae (351GR1),F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,252675,=,1,1,=,,ED50,mg.kg-1,,109.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,ED50,mg kg-1,UO_0000308,,109.0
189925,,,447192,[],CHEMBL699399,In Vivo evaluation for its effective dose against Haemophilus influenzae (351TO19 AmpR beta (-)),F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,252675,=,1,1,=,,ED50,mg.kg-1,,368.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,ED50,mg kg-1,UO_0000308,,368.0
189926,,,447193,[],CHEMBL694439,In Vivo evaluation for its effective dose against Haemophilus influenzae (351RD7 AmpR beta (+)),F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131139,J Med Chem,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,252675,=,1,1,=,,ED50,mg.kg-1,,117.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,ED50,mg kg-1,UO_0000308,,117.0
189927,,,458191,[],CHEMBL813783,Compound was evaluated for antibacterial activity against Streptococcus pneumoniae (MB3957) sensitive strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1130816,Bioorg Med Chem Lett,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,37066,<,1,1,<,,MIC,ug.mL-1,,60.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg ml-1,UO_0000274,,0.06
189928,,,458192,[],CHEMBL808955,Compound was evaluated for antibacterial activity against Streptococcus pyogenes (MB2874) sensitive strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1130816,Bioorg Med Chem Lett,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,37066,=,1,1,=,,MIC,ug.mL-1,,30.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,mg ml-1,UO_0000274,,0.03
189929,,,458193,[],CHEMBL807854,Compound was evaluated for antibacterial activity against Staphylococcus aureus (MB2865) sensitive strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1130816,Bioorg Med Chem Lett,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,37066,=,1,1,=,,MIC,ug.mL-1,,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg ml-1,UO_0000274,,0.5
189930,,,458194,[],CHEMBL679800,Compound was evaluated for antibacterial activity against Enterococcus faecalis (MB5407) sensitive strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1130816,Bioorg Med Chem Lett,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,37066,=,1,1,=,,MIC,ug.mL-1,,4000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mg ml-1,UO_0000274,,4.0
189931,,,458195,[],CHEMBL673987,Compound was evaluated for antibacterial activity against Enterococcus faecium (MB5516) sensitive strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1130816,Bioorg Med Chem Lett,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,37066,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,mg ml-1,UO_0000274,,0.25
189932,,,458196,[],CHEMBL651891,Compound was evaluated for antibacterial activity against Bacillus subtilis (MB5586) sensitive strain,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1130816,Bioorg Med Chem Lett,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,37066,=,1,1,=,,MIC,ug.mL-1,,1000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,mg ml-1,UO_0000274,,1.0
189933,,,464909,[],CHEMBL624569,Observed volume of distribution,A,,,BAO_0003041,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1148291,J Med Chem,2004.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,29106,=,1,1,=,,Vdss,L.kg-1,,33.0,CHEMBL612558,,ADMET,,,,Vdss,l kg-1,UO_0000197,,33.0
189934,,,464910,[],CHEMBL618310,Unbound fraction (plasma),A,,,BAO_0000179,BAO_0000366,cell-free format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1148291,J Med Chem,2004.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,29106,=,1,1,=,,Fu,,,0.88,CHEMBL612558,,ADMET,,,,Fu,,,,0.88
189935,,,464911,[],CHEMBL633292,Ionization constant (pKa),P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1148291,J Med Chem,2004.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,29106,=,1,0,=,,pKa,,,8.74,CHEMBL2362975,,No relevant target,,,,pKa,,,,8.74
189936,,,464912,[],CHEMBL633292,Ionization constant (pKa),P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1148291,J Med Chem,2004.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,29106,=,1,0,=,,pKa,,,9.45,CHEMBL2362975,,No relevant target,,,,pKa,,,,9.45
189937,,,485070,[],CHEMBL745309,Compound was evaluated for in vitro anti-mycobacterial activity against Mycobacterium avium complex (MAC) ATCC 49601,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1129577,J Med Chem,1996.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,314388,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,4.0
189938,,,485071,[],CHEMBL744960,Compound was evaluated for in vitro anti-mycobacterial activity against MAC 101,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1129577,J Med Chem,1996.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,314388,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,4.0
189939,,,485072,[],CHEMBL751648,Compound was evaluated for in vitro anti-mycobacterial activity against Mycobacterium simiae,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1129577,J Med Chem,1996.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,314388,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614988,Mycobacterium simiae,Mycobacterium simiae,1784.0,,,MIC,ug ml-1,UO_0000274,,4.0
189940,,,485073,[],CHEMBL752461,Compound was evaluated for in vitro anti-mycobacterial activity against Mycobacterium xenopi,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1129577,J Med Chem,1996.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,314388,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612642,Mycobacterium xenopi,Mycobacterium xenopi,1789.0,,,MIC,ug ml-1,UO_0000274,,1.0
189941,,,485074,[],CHEMBL751367,Compound was evaluated for in vitro anti-mycobacterial activity against Mycobacterium malmoense,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1129577,J Med Chem,1996.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,314388,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613090,Mycobacterium malmoense,Mycobacterium malmoense,1780.0,,,MIC,ug ml-1,UO_0000274,,16.0
189942,,,485075,[],CHEMBL748682,Compound was evaluated for in vitro anti-mycobacterial activity against Mycobacterium fortuitum,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1129577,J Med Chem,1996.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,314388,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC,ug ml-1,UO_0000274,,64.0
189943,,,726086,[],CHEMBL878287,In vitro minimum inhibitory concentration against Enterococcus faecalis MB5407.,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1151508,Bioorg Med Chem Lett,1994.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,13109,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
189944,,,726087,[],CHEMBL814109,In vitro minimum inhibitory concentration against Staphylococcus aureus MB2865.,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1151508,Bioorg Med Chem Lett,1994.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,13109,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
189945,,,726088,[],CHEMBL808408,In vitro minimum inhibitory concentration against Streptococcus pneumoniae CL2883.,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1151508,Bioorg Med Chem Lett,1994.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,13109,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
189946,,,726089,[],CHEMBL680447,In vitro minimum inhibitory concentration against Escherichia coli MB2884.,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1151508,Bioorg Med Chem Lett,1994.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,13109,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
189947,,,726090,[],CHEMBL694347,In vitro minimum inhibitory concentration against Haemophilus influenzae MB5363.,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1151508,Bioorg Med Chem Lett,1994.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,13109,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
189948,,,726091,[],CHEMBL702479,In vitro minimum inhibitory concentration against Klebsiella pneumoniae MB4005.,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1151508,Bioorg Med Chem Lett,1994.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,13109,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
189949,,,843291,[],CHEMBL808931,The compound was tested in vitro for antibacterial activity against erythromycin susceptible Staphylococcus aureus 011UC4,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3
189950,,,843292,[],CHEMBL808933,The compound was tested in vitro for antibacterial activity against inducibly erythromycin resistant Staphylococcus aureus 011GO25i,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,40.0
189951,,,843293,[],CHEMBL810474,The compound was tested in vitro for antibacterial activity against constitutively erythromycin resistant Staphylococcus aureus 011CB20,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,40.0
189952,,,843294,[],CHEMBL809711,The compound was tested in vitro for antibacterial activity against erythromycin susceptible Streptococcus pyogenes 02A1UC1,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,,MIC,ug.mL-1,,0.6,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.6
189953,,,843295,[],CHEMBL857923,The compound was tested in vitro for antibacterial activity against erythromycin susceptible Streptococcus pneumoniae 032UC1,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,,MIC,ug.mL-1,,0.15,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.15
189954,,,843296,[],CHEMBL809209,The compound was tested in vitro for antibacterial activity against constitutively erythromycin resistant Streptococcus pneumoniae 030PW23c,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,40.0
189955,,,843297,[],CHEMBL809207,The compound was tested in vitro for antibacterial activity against constitutively erythromycin resistant Streptococcus pneumoniae 030CR18c,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,40.0
189956,,,843298,[],CHEMBL809211,The compound was tested in vitro for antibacterial activity against constitutively erythromycin resistant Streptococcus pneumoniae 030SJ1,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,40.0
189957,,,843299,[],CHEMBL814666,The compound was tested in vitro for antibacterial activity against inducibly erythromycin resistant Streptococcus pneumoniae 030J5i,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,40.0
189958,,,843300,[],CHEMBL690594,The compound was tested in vitro for antibacterial activity against Haemophilus influenza 351HT3,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,,MIC,ug.mL-1,,1.2,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,1.2
189959,,,843301,[],CHEMBL673725,The compound was tested in vitro for antibacterial activity against Escherichia coli 250 UCS,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,195318,=,1,1,=,,MIC,ug.mL-1,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,20.0
189960,,,843302,[],CHEMBL804689,The compound was tested in vitro for antibacterial activity against 66 strains of inducibly erythromycin resistant Staphylococci; Value is 40/40,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,,1,0,,,MIC50/MIC90,,,,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC50/MIC90,,,,
189961,,Not Determined,843303,[],CHEMBL807190,The compound was tested in vitro for antibacterial activity against 23 strains of constitutively erythromycin resistant Staphylococci; Not determined,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,,1,0,,,MIC50/MIC90,,,,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC50/MIC90,,,,
189962,,,843304,[],CHEMBL806144,The compound was tested in vitro for antibacterial activity against 31 strains of erythromycin resistant Streptococci; Value is 10/40,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,,1,0,,,MIC50/MIC90,,,,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC50/MIC90,,,,
189963,,,843305,[],CHEMBL814676,The compound was tested in vitro for antibacterial activity against 32 strains of inducibly erythromycin resistant Streptococcus pneumoniae; Value is 40/40,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,,1,0,,,MIC50/MIC90,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50/MIC90,,,,
189964,,,843306,[],CHEMBL814679,The compound was tested in vitro for antibacterial activity against 40 strains of constitutively erythromycin resistant Streptococcus pneumoniae; Value is 40/40,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,,1,0,,,MIC50/MIC90,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50/MIC90,,,,
189965,,,843307,[],CHEMBL817374,The compound was tested in vitro for antibacterial activity against 53 strains of Streptococcus pneumoniae PenR; Value is 2.5/40,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,,1,0,,,MIC50/MIC90,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50/MIC90,,,,
189966,,,843308,[],CHEMBL694273,The compound was tested in vitro for antibacterial activity against 47 strains of Haemophilus influenza AmpS; Value is 0.15/1.2,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,,1,0,,,MIC50/MIC90,,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50/MIC90,,,,
189967,,,843309,[],CHEMBL690597,The compound was tested in vitro for antibacterial activity against 39 strains of Haemophilus influenza AmpR; Value is 1.2/10,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,,1,0,,,MIC50/MIC90,,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50/MIC90,,,,
189968,,,843310,[],CHEMBL743149,The compound was tested in vivo for antibacterial activity against erythromycin susceptible Staphylococcus aureus 011UC4 in mice after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,=,1,1,=,,ED50,mg.kg-1,,30.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,30.0
189969,,,843311,[],CHEMBL743152,The compound was tested in vivo for antibacterial activity against inducibly erythromycin resistant Staphylococcus aureus 011GO3 in mice after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,>,1,1,>,,ED50,mg.kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,100.0
189970,,,843312,[],CHEMBL743150,The compound was tested in vivo for antibacterial activity against erythromycin susceptible Streptococcus pneumoniae 032UC1 in mice after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,=,1,1,=,,ED50,mg.kg-1,,6.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,6.0
189971,,,843313,[],CHEMBL743153,The compound was tested in vivo for antibacterial activity against inducibly erythromycin resistant Streptococcus pneumoniae 030RO1 in mice after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,>,1,1,>,,ED50,mg.kg-1,,50.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,50.0
189972,,,843314,[],CHEMBL743140,The compound was tested in vitro for antibacterial activity against constitutively erythromycin resistant Streptococcus pneumoniae 030SJ6.,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,>,1,1,>,,ED50,mg.kg-1,,50.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,50.0
189973,,,843315,[],CHEMBL743146,The compound was tested in vivo for antibacterial activity against constitutively erythromycin resistant Streptococcus pneumoniae 030MV2 in mice after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,>,1,1,>,,ED50,mg.kg-1,,50.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,50.0
189974,,,843316,[],CHEMBL743147,The compound was tested in vivo for antibacterial activity against constitutively erythromycin resistant Streptococcus pneumoniae 030SJ1 in mice after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,>,1,1,>,,ED50,mg.kg-1,,50.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,50.0
189975,,,843317,[],CHEMBL743145,The compound was tested in vivo for antibacterial activity against constitutively erythromycin resistant Streptococcus pneumoniae 030Cr29 in mice after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,>,1,1,>,,ED50,mg.kg-1,,50.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,50.0
189976,,,843318,[],CHEMBL743151,The compound was tested in vivo for antibacterial activity against erythromycin susceptible Streptococcus pyogenes 02A1UC1 in mice after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,=,1,1,=,,ED50,mg.kg-1,,16.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,16.0
189977,,,843319,[],CHEMBL743144,The compound was tested in vivo for antibacterial activity against Haemophilus influenza 351GR1 in mice after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,=,1,1,=,,ED50,mg.kg-1,,56.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,56.0
189978,,,843320,[],CHEMBL743143,The compound was tested in vivo for antibacterial activity against AmpR beta(-) Haemophilus influenza 351TO19 in mice after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,=,1,1,=,,ED50,mg.kg-1,,145.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,145.0
189979,,,843321,[],CHEMBL743142,The compound was tested in vivo for antibacterial activity against AmpR beta(+) Haemophilus influenza 351RD7 in mice after oral administration,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131863,Bioorg Med Chem Lett,1999.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,195318,=,1,1,=,,ED50,mg.kg-1,,94.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,ED50,mg kg-1,UO_0000308,,94.0
189980,,Active,889293,[],CHEMBL694438,Antibacterial activity against Haemophilus influenzae; Active,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1129675,J Med Chem,1996.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,241418,,1,0,,,Activity,,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Activity,,,,
189981,,Active,889294,[],CHEMBL707895,Antibacterial activity against Legionella; More active,F,,,BAO_0000375,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1129675,J Med Chem,1996.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,241418,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
189982,,Active,889295,[],CHEMBL876527,Antibacterial activity against Brahmella species.; More active,F,,,BAO_0000375,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1129675,J Med Chem,1996.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,241418,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
189983,,Active,889296,[],CHEMBL661476,Antibacterial activity against Chlamydia; More active,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1129675,J Med Chem,1996.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,241418,,1,0,,,Activity,,,,CHEMBL614410,Chlamydia,Chlamydia,810.0,,,Activity,,,,
189984,,Active,889297,[],CHEMBL761253,Antibacterial activity against Pasteurella multocida; More active,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1129675,J Med Chem,1996.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,241418,,1,0,,,Activity,,,,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,Activity,,,,
189985,,Active,889298,[],CHEMBL805376,Antibacterial activity against Streptococci; More active,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1129675,J Med Chem,1996.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,241418,,1,0,,,Activity,,,,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,Activity,,,,
189986,,,894771,[],CHEMBL857238,Minimum inhibitory concentration against macrolide susceptible strain of Streptococcus pneumoniae (MB3957),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,<,1,1,<,,MIC,ug.mL-1,,60.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg ml-1,UO_0000274,,0.06
189987,,,894772,[],CHEMBL809184,Minimum inhibitory concentration against macrolide susceptible strain of Streptococcus pyogenes (MB2874),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,=,1,1,=,,MIC,ug.mL-1,,30.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,mg ml-1,UO_0000274,,0.03
189988,,,894773,[],CHEMBL812137,Minimum inhibitory concentration against macrolide susceptible strain of Staphylococcus aureus (MB2865),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,=,1,1,=,,MIC,ug.mL-1,,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg ml-1,UO_0000274,,0.5
189989,,,894774,[],CHEMBL678979,Minimum inhibitory concentration against macrolide susceptible strain of Enterococcus faecalis (MB5407),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,=,1,1,=,,MIC,ug.mL-1,,4000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mg ml-1,UO_0000274,,4.0
189990,,,894775,[],CHEMBL878280,Minimum inhibitory concentration against macrolide susceptible strain of Enterococcus faecium (MB5516),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,mg ml-1,UO_0000274,,0.25
189991,,,894776,[],CHEMBL650971,Minimum inhibitory concentration against macrolide susceptible strains of Bacillus subtilis (MB5586),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,=,1,1,=,,MIC,ug.mL-1,,1000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,mg ml-1,UO_0000274,,1.0
189992,,,894777,[],CHEMBL748702,Minimum inhibitory concentration against macrolide susceptible strains of Mycobacterium smegmatis (MC2155),F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1131642,Bioorg Med Chem Lett,1998.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,297856,=,1,1,=,,MIC,ug.mL-1,,4000.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,mg ml-1,UO_0000274,,4.0
189993,,,927449,[],CHEMBL760551,Minimum inhibitory concentration against Pasteurella multocida,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1130001,J Med Chem,1997.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,39517,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC,ug ml-1,UO_0000274,,0.05
189994,,,927450,[],CHEMBL722018,"Protective dose at which 50% of infected, treated mice survive",F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1130001,J Med Chem,1997.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,39517,=,1,0,=,,PD50,mg kg-1,,16.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,16.0
189995,,,927451,[],CHEMBL875169,Dissociation constant (pKa),P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1130001,J Med Chem,1997.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,39517,=,1,0,=,,pKa1,,,8.74,CHEMBL2362975,,No relevant target,,,,pKa1,,,,8.74
189996,,,927452,[],CHEMBL634052,Dissociation constant (pKa),P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1130001,J Med Chem,1997.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,39517,=,1,0,=,,pKa2,,,9.45,CHEMBL2362975,,No relevant target,,,,pKa2,,,,9.45
189997,,,927453,[],CHEMBL630700,The negative logarithm of the fraction of neutral molecules,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1130001,J Med Chem,1997.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,39517,=,1,0,=,,pNF,,,3.41,CHEMBL612558,,ADMET,,,,pNF,,,,3.41
189998,,,927454,[],CHEMBL633444,The negative logarithm of the fraction of singly charged molecules.,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1130001,J Med Chem,1997.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,39517,=,1,0,=,,pCF,,,1.36,CHEMBL612558,,ADMET,,,,pCF,,,,1.36
189999,,,927455,[],CHEMBL632771,Calculated partition coefficient (clogP),P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1130001,J Med Chem,1997.0,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,39517,=,1,1,=,,CLogP,,,4.02,CHEMBL2362975,,No relevant target,,,,clogP,,,,4.02
